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Osteoarthritis
osteoarthritis (oA) is the most frequent joint disorder worldwide and causes a consider-
able burden of pain, disability, and ever increasing costs to society.1 Due to rapid ageing 
and the epidemic of obesity in western populations, prevalence of oA is expected to 
increase even more, by approximately 20% in the next 10 years. This will make oA the 
fourth leading cause of disability.2
oA can occur in every synovial joint, but is most common in the hips, knees, hands, 
feet and spine.3 histologically, it is characterized by loss of cartilage structure, subchon-
dral bone sclerosis, synovial inflammation and osteophyte formation, with affection of 
the whole joint (i.e. joint failure).4 (Figure 1)
oA is considered to be a multifactorial disease and its aetiology involves biomechani-
cal, genetic, inflammatory and hormonal factors. over the last decades, interactions 
between these risk factors have been identified in epidemiological and experimental 
studies, adding to our understanding of the complexity of this chronic progressive 
disorder. For instance, the effect of obesity on knee osteoarthritis is amplified if hyper-
tension is present, which might reflect an accumulative effect of cardiovascular risk 
factors.5 Furthermore, malalignment of the knee seems to be a risk factor for knee oA 
only among obese individuals.6,7 In addition to the interaction between risk factors, 
different risk factors are related to oA in different joints.8
a Normal b Osteoarthritis
Figure 1. overview of joint tissues involved in the osteoarthritic disease process.
4 Chapter 1
oA might be seen as a result of a common pathway secondary to many predisposing 
factors (Figure 2). Although the mechanism leading to the initiation and progression 
of oA remains largely unknown, it is well known that the disease process ultimately 
leads to pain or disability.9 For more than a decade, much effort has been made in oA 
research to find disease-modifying drugs, mainly targeting the cartilage. unfortunately, 
at present only symptomatic treatment for oA is available, with minor effectiveness.10
Several epidemiological studies have identified age, female sex and obesity as key 
risk factors for oA. The involvement of other potential risk factors such as diabetes11, 
menopause12,13, and cholesterol14 in the disease process suggests that oA could be part 
of the metabolic syndrome15, a condition with as its main characteristic systemic 
inflammation caused by visceral adipose tissue.16 An important clinical manifesta-
tion of the metabolic syndrome is atherosclerosis. In this thesis, we will focus on the 
chronic inflammatory process of atherosclerosis and its relation to osteoarthritis in a 
population-based setting, since several epidemiological studies have indicated a rela-
tion between subclinical measures of atherosclerosis and oA.17-19
http://www.sciencedirect.com/cache/MiamiImageURL/1-s2.0-S0140673605710862-gr4_lrg.jpg/0?wchp=dGLzVBA-zSkWW&pii=S0140673605710862[06-08-2014 15:21:54]
Figure 2. Risk factors involved in the aetiology of oA and its consequences as presented by Dieppe 
and Lohmander.9
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Vascular pathology
Atherosclerosis is the underlying cause of 50% of all deaths in western societies.20 In 
short, it is a multifactorial progressive condition characterized by the accumulation 
of lipids and fibrous elements in the arterial walls. The accumulation of lipids in the 
arteries over time can be viewed as a ‘response to injury’ caused by an unhealthy 
environment, genetic susceptibility or other risk factors as the injurious agents.20-22 
Figure 3 shows the inflammatory pathway of atherosclerosis three-dimensionally 
on a gliding scale and reflects its complex aetiology. Interaction between risk factors 
(similar to the aetiology of oA) adds to this complexity. eventually, accumulation of 
risk factors or ‘injuries’ in the chronic inflammatory process of atherosclerosis results 
in an acute clinical event (such as a myocardial infarction or stroke) by plaque rupture 
and thrombosis (see also figure 3).20 The exact trigger for a clinical event remains an 
area of debate.
Vascular Pathology and osteoarthritis
An association between cardiovascular events and oA has been reported repeatedly.23-25 
Cerhan et al.26 showed overall cardiovascular mortality to be directly proportional to 
the extent of radiographic evidence of oA, implying a dose-response relationship. Sev-
eral explanations have been suggested for these associations; the common treatment 
of oA with non-steroidal anti-inflammatory drugs (nSAIDs), which increase the risk for 
myocardial events, as well as a lack of exercise due to the presence of oA.27 however, 
a Finnish study showed that oA in any finger joint predicted cardiovascular death28, 
a type of oA for which long term nSAID use is not common and that hardly causes 
inactivity. Another explanation focuses on the shared association with obesity. Poor 
Figure 3. Pathophysiology of atherosclerosis.
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fetal growth, or an altered lipid metabolism has also been suggested as a potential 
shared causal mechanism.27,29,30
Recently, Saleh et al.19 showed an association between arterial stiffness and hand 
oA. In addition, Jonsson et al.18 showed that carotid and coronary atherosclerosis were 
associated with hand oA, in women but not in men. Both studies were cross-sectional 
in design. Saleh et al.19 proposed that this relationship arises from an accumulation of 
advanced glycation end-products in both cartilage and arteries, or alternatively from 
oxidative stress in both cartilage and arteries. hence, atherosclerosis and oA could be 
concurrent diseases with a shared aetiology. however, Jonsson et al. suggested that 
atherosclerosis plays an initiating role in oA; circulatory disturbances in the synovial 
membrane and subchondral bone could contribute to the cartilage destruction and 
the pathophysiological process of osteoarthritis.18 This may occur through mechanical 
changes of the subchondral bone, or more directly through bone-derived cytokines 
causing degradation of the cartilage.
There already is convincing evidence that areas of bone marrow edema in the sub-
chondral bone predict oA progression31-33 and that these are present early on in the 
disease.34 histologically, bone marrow edema is an area of necrosis and remodeling35 
and may represent ischaemic areas in the bone similar to those in avascular necrosis.36 
Conaghan et al.27 argued that atherosclerosis might be of even more importance for the 
progression of oA than for the initiation of oA and postulated that the subchondral 
bone ischaemia theory is the most likely one to explain that link.
Taken together, atherosclerosis and oA might be associated but it is still unclear 
whether these diseases are concurrent diseases or whether vascular pathology plays 
a causal role in oA. Several hypotheses have been formulated to explain the apparent 
link, but longitudinal population-based studies are lacking.
Overall aim of the thesis
The goal of this thesis is to investigate whether atherosclerosis and oA are concurrent 
conditions with shared pathophysiological mechanisms or rather that atherosclerosis 
acts as a risk factor for oA. This knowledge may be crucial: if atherosclerosis turns 
out to play an important role in the initiation of oA, this may stimulate a new way of 
thinking about oA pathology, with new alternatives for disease modifying treatment 
or even the prevention of oA as a result.
our primary research questions are:
1. Are subclinical measures of atherosclerosis detected by imaging or in serum associ-
ated with prevalent radiographic hand oA, hip oA, or knee oA?
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2. Do subclinical measures of atherosclerosis detected by imaging or in serum predict 
the development and progression of radiographic hand oA, hip oA, or knee oA?
3. Are subclinical measures of atherosclerosis detected by imaging associated with 
subchondral bone marrow edema ( anearly feature of knee oA) in women without 
radiographic knee oA?
our secondary research questions are:
4. If the association between atherosclerosis and oA is more pronounced in women, is 
this related to years since menopause?
5. Is oA an additional risk factor for incident cardiovascular disease?
In order to answer our research questions, we obtained data from a longitudinal 
population-based cohort study; the Rotterdam Study. All studies in this thesis were 
part of the project “vascular pathology and osteoarthritis”, supported by a grant from 
the Reumafonds (Dutch Arthritis Foundation).
Study population
The Rotterdam Study was set up in 1989 to investigate the occurrence and determinants 
of diseases in middle-aged and elderly populations. Inclusion of participants is visual-
ized in figure 4. In short, all 10,275 inhabitants aged 55 years and older who had been 
living for at least 1 year in the ommoord district of the city of Rotterdam were invited 
to participate (cohort RS-I-1) at the beginning of the study. The response rate was 78%, 
meaning that 7,983 subjects responded. In 2000, 3,011 participants (out of 4,472 invitees) 
who had become 55 years of age or had moved into the study district since the start of 
the study were added to the cohort (RS-II-1). In 2006, a further extension of the cohort 
was initiated in which 3,932 subjects were included, aged 45-54 years, out of 6,057 
invited (RS-III-1). Therefore, by the end of 2008 the Rotterdam Study comprised 14,926 
subjects aged 45 years or over.37 All participants take part in extensive examinations, 
including blood sampling, interviews, physical examinations, ultrasounds and X-rays, 
among other. Follow-up takes place every 4-5 years and the study base is digitally linked 
to medical records of general practitioners and a pharmacy in the ommoord area.
The burden of atherosclerosis is visualized in the Rotterdam Study by noninvasive 
methods. ultrafast computerized tomography and extravascular ultrasound assess 
coronary artery calcification (RS-I-3), carotid intima-media thickness, and carotid 
plaque (RS-I-1/RS-III-1). These subclinical measures of atherosclerosis reflect changes in 
the vascular wall over time and are strong predictors of coronary heart disease and 
cardiovascular events.38-41 Another way to diagnose atherosclerosis is to use more inva-
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sive measures. Catherization is the gold standard, but undesirable for financial reasons 
and because of significant risks. Certain biochemical markers for the disease, such as 
vascular cell adhesion molecule and vascular endothelial growth factor are considered 
more useful42,43 and were available in cohort RS-I-3.
To define oA, radiographs, symptoms, and magnetic resonance imaging (MRI) are 
used. half a century ago, Kellgren & Lawrence (K&L) composed a 5-point (0-4) grading 
scale using radiographic changes that is still widely used and recommended for the 
proper determination of radiographic oA today. Within the Rotterdam Study, a grade 5 
for total joint replacements was added to the K&L scale. Radiographs were available in 
cohorts RS-I-1, RS-I-3, RS-I-4, RS-II-1, and RS-III-1. We defined clinical oA as a K&L grade≥2 
and reported pain in the same joint in the past month, similar to the definition devel-
oped for scientific studies by the American College of Rheumatology.44 This was done 
in cohort RS-I-1. MRI has the advantage of providing a three-dimensional view of the 
(mainly knee) joint and can detect more subtle structural abnormalities in an earlier 
phase of the oA disease process than radiographs. MRIs of the knees were available in 
a nested cohort of almost 900 randomly selected women in RS-III-1.
To summarize, the Rotterdam Study, comprising a huge data set of an adult popula-
tion with prospective data on a large number of objective measurements of athero-
sclerosis, confounding factors, and features of local and widespread oA over a ten year 
period, gives us the unique opportunity to disentangle the mechanism of interaction 
between atherosclerosis and oA.
Figure 4. Design of the Rotterdam Study.
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Outline of this thesis
Chapter 2 describes subclinical measures of atherosclerosis and their relation with the 
presence and progression of osteoarthritis of the knee, hip, and the different hand joints 
in the first cohort of the Rotterdam Study (Questions 1, 2, and 4). The same cohort, only 
older, is investigated in Chapter 3. Additional markers of early and late atherosclerosis 
in relation to the presence and progression of knee osteoarthritis are presented and 
evaluated. Chapter 4 reports on the association between carotid atherosclerosis and 
early features of knee osteoarthritis in middle-aged women (Questions 3 and 4). These 
first chapters discuss atherosclerosis and oA as concurrent diseases and atherosclerosis 
as an initiator or progressor of oA. The association between clinical manifestations of 
the metabolic syndrome and oA is complex, and prone to confounding factors, which 
hampers interpretation when classical epidemiological methods are used. In chapter 
5, we therefore explored Mendelian randomisation (instrumental-variable-approach), 
which uses genetic variation as a surrogate marker for a risk factor. In contrast to ath-
erosclerosis and oA, many single nucleotide polymorphisms are known for glycemic 
traits with moderate to large effect sizes. We investigated whether genetically defined 
elevated levels of fasting glucose and fasting insulin were associated with oA. Chapter 
6 provides evidence on the relation between osteoarthritis and cardiovascular events 
(Question 5). Is it an additional risk factor for incident cardiovascular disease or not? 
Finally, Chapter 7 reflects on the main findings of the preceding chapters, as well as 
their limitations. Furthermore, implications for future research and clinical practice 
are discussed.
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Abstract
Objective
We examined whether vascular alterations are associated with the presence and pro-
gression of osteoarthritis (oA) of the knee, the hip, and the different hand joints in a 
large prospective cohort study.
Methods
In this population-based study involving participants aged 55 years and older (Rotter-
dam Study-I), men (n=2,372) and women (n=3,278) were analyzed separately. We scored 
X-rays of the knee, hip and hand using the Kellgren & Lawrence (K&L) score for oA 
at baseline, after 6.6 years and 10 years. Measures of atherosclerosis (carotid intima 
media thickness (IMT) and carotid plaque) and data on covariates (age, body mass in-
dex, hypertension, cholesterol ratio, diabetes mellitus and smoking) were collected at 
baseline. Multivariate logistic regression models with generalized estimated equations 
were used to calculate odds ratios and corresponding 95% confidence intervals. Second-
ary multiple comparisons adjustment resulted in a significance level of p<0.0021.
Results
In women, IMT showed an independent association with prevalence of knee oA (ad-
justed odds ratio (aoR) 1.7 (1.1 - 2.7)), and carotid plaque with distal interphalangeal 
(DIP) oA (aoR 1.4 (1.2 - 1.7)) and with metacarpophalangeal (MCP) oA (aoR 1.5 (1.1 - 2.2)). 
An independent association for IMT with progression of MCP oA was found in women 
(aoR 2.9 (1.18 - 6.93). Additional adjustment for multiple testing yielded a significant 
association between carotid plaque and DIP oA in women (p<0.001).
Conclusions
This study showed independent associations of atherosclerosis with oA of the knee and 
hand joints in women. The evidence was most solid for a relation with DIP oA. More 
research is needed to confirm the associations and examine the differential association 
with various joints.
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Introduction
osteoarthritis (oA) is a highly prevalent joint disorder that causes a huge burden of 
pain and disability [1]. It is characterized by loss of cartilage structure, subchondral 
bone sclerosis, synovial inflammation and osteophyte formation, with affection of the 
whole joint (i.e. joint failure) [2]. Different risk factors have been suggested for oA, 
among these age, female gender and obesity are the key ones. The involvement of 
other potential risk factors like diabetes [3], menopause [4,5], and cholesterol [6] in the 
disease process suggest that oA could be part of or linked to the metabolic syndrome 
[7]. In addition, a higher risk of cardiovascular death has been reported for patients 
with knee or hip oA [8].
Atherosclerosis is an important feature of cardio-metabolic disorders. Although 
some studies have indicated that atherosclerosis is associated with oA, they are few 
in number, often lack sufficient power and are cross-sectional only. As a result, it is 
unclear whether atherosclerosis and oA are associated, either as concurrent diseases 
due to a common aetiology or causally related. Furthermore, whether there are dif-
ferences in association with vascular diseases between joints affected by oA remains 
undetermined.
Therefore, using data from a large longitudinal population-based study, we inves-
tigated the role that atherosclerosis might play in the prevalence, but also in the 
incidence and progression of oA and examined whether this association might vary by 
types of joints, gender and other key factors.
Methods
Study Population
The Rotterdam Study is a prospective population-based cohort study that was set up 
in 1989 to investigate the occurrence and determinants of diseases in middle age and 
elderly populations [9]. All 10.275 inhabitants aged 55 years and older who had been 
living for at least 1 year in the ommoord district of the city of Rotterdam were invited 
to participate. The response rate was 78%, meaning that 7983 subjects responded. All 
participants gave written informed consent and the study was approved by the ethics 
committee of the erasmus university Medical Centre, Rotterdam. Baseline measure-
ments were obtained from 1990 to 1993 and consisted of a home interview and visits 
to the research centre for physical examinations. Follow-up data were collected during 
follow-up visits from 1997 to 2000 and from 2002 to 2005. In 2011, we included partici-
pants for whom radiographs of knees, hips or hands at baseline and follow-up were 
available and had been scored.
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Measures of atherosclerosis
A 7.5-Mhz linear array transducer with a Duplex scanner (ATL ultraMark Iv) was used 
for ultrasonography of both carotid arteries. on a longitudinal two-dimensional ul-
trasound image of the carotid artery, the near and far walls of the carotid artery were 
displayed as two bright white lines separated by a hypoechogenic space. The distance 
from the leading edge of the first bright line of the far wall (lumen-intima interface) 
to the leading edge of the second bright line (media-adventitia interface) indicated the 
intima media thickness (IMT). Data on IMT was available for 3369 women and 2275 
men. Reproducibility assessed by the intraclass correlation coefficient was 0.74 [10].
The presence of plaques in the carotid artery was assessed by examining the ul-
trasonographic images of the common, internal, and bifurcation sites of the carotid 
artery for presence of atherosclerotic lesions. Plaques were defined as a focal widening 
relative to adjacent segments, with protrusion into the lumen composed of either only 
calcified deposits or a combination of calcified and noncalcified material [11,12]. Data 
on presence of plaque was available for 2665 women and 1808 men. Readers of the 
ultrasound images were unaware of the case status of the subject.
Assessment of OA
Standard anteroposterior radiographs of both hands were scored by three trained as-
sessors. each joint was graded for overall radiographic oA using a Kellgren-Lawrence 
(K&L) grade scaled 0-4 (see supplementary table S1). Radiographic oA was defined as a 
K&L grade ≥2. DIPs, PIPs, MCPs and CMC/TS groups were defined as positive if the K&L 
score in at least one joint in the group was ≥2. Interobserver reliability of K&L score of 
2 or more as a dichotomous variable expressed by the intraclass correlation coefficient 
was as follows: DIPs; 0.69, PIPs; 0.74, MCPs; 0.70, CMC/TS (base of thumb); 0.84. After 
consultation of an expert, we excluded hand X-rays with signs of rheumatoid arthritis 
or fractures. X-rays of the hand were available at baseline for 3210 women and 2428 
men and after 10 years of follow-up for 1385 women and 1057 men. Progression of hand 
oA was defined as 1 grade increase in the K&L scale. This was done for each of the 
handjoint groups separately (Kerkhof hJM, 2011, unpublished data).
Knee and hip X-rays were taken and scored with a K&L grade scaled 0-4 (see supple-
mentary table S1). Radiographs of the pelvis were obtained when both feet were rotated 
10° inward and the X-ray beam was centred on the umbilicus and knee radiographs 
were taken with the knee extended and the patella in a central position. The intraclass 
correlation coefficient was 0.71 for the knee and 0.74 for the hip [13,14]. Knee and hip 
oA progression were defined as an increase in the K&L score between baseline and 
follow-up of 1 or more [15]. X-rays of the knee and hip were available at baseline for 
3278 women and 2372 men, after 6.6 years for 2449 women and 1232 men, and after 
10 years for 1149 women and 941 men. If X-rays were available after 6.6 years, but not 
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after 10 years of follow-up, data was forwarded. Assessment of oA was done blinded for 
clinical and demographic data.
Co-factors
Trained interviewers gathered information on medical history and risk factors for 
chronic diseases. Participants were invited to visit the research centre for clinical ex-
aminations and laboratory assessments. The following information was collected: age; 
body mass index (BMI; weight (kg)/height (m2)); total cholesterol/high density lipopro-
tein (hDL) ratio (serum total cholesterol determined by an enzymatic procedure; hDL 
measured after precipitation of non-hDL cholesterol); current smoking (self-reported); 
diabetes mellitus (use of glucose lowering medication or non-fasting random or post 
load glucose levels exceeding 11.0 mmol/liter); and arterial hypertension (systolic blood 
pressure of 140 mmhg or higher, diastolic blood pressure of 90 mmhg or higher, or use 
of antihypertensive drugs for hypertension).
Statistical analysis
We analyzed the association between atherosclerosis and the presence of osteoarthritis 
using multivariate logistic regression models in which IMT and plaque were included 
separately for the calculation of odds ratios and 95% confidence intervals. Thickness of 
the common carotid arteries (IMT) was analyzed continuously. Presence of plaque was 
treated as a binary variable in the analysis. Different models were built to provide insight 
in how the link between atherosclerosis and oA might be driven (non-adjusted, age ad-
justed, age and BMI adjusted, and fully adjusted). The inclusion of potential confounding 
variables such as age, body mass index, total cholesterol/hDL ratio, diabetes, hyperten-
sion and smoking was based on existing literature about risk factors for cardiovascular 
disease and oA and following initial univariate evaluation. In addition, adjustments 
for follow-up time and baseline K&L score were made for the multivariate analyses on 
progression of oA. We used generalized estimating equations (Gee), a mixed logistic 
regression model, to adjust for correlations between the right and left extremity in each 
individual and to increase discriminative ability. Because the definition of progression 
implies that participants are conditioned by the baseline presence of oA the estimates 
of an effect of exposure (atherosclerosis) on outcome (oA) might be biased. We therefore 
again included all potential confounders in the model to minimize conditioning by base-
line [16]. Subjects with missing values were excluded from the analysis. Stratification 
by sex was based on previous studies [17,18]. our a priori p-value threshold was set at 
P ≤ 0.05. however, due to multiple comparisons for the different joint groups, the two 
measures of atherosclerosis, and both genders we further examined the associations 
in a second analysis for the more rigorous p-value of p<0.0021 (a/24). We performed all 
analyses with the Statistical Package for Social Sciences (SPSS) version 17.0.
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Results
General characteristics
of the total 7983 participants, 3278 women and 2372 men were included in this study. 
Because they did not have X-rays taken at baseline, 2333 participants were excluded. 
Table 1 shows the baseline characteristics of the study population, overall and strati-
fied by sex. The mean age of the population at baseline was 68.2 years; 58% were 
female. In this study, women were slightly older (68.6 years vs. 67.5 years), had a higher 
BMI (26.8 kg/m² vs. 25.7 kg/m²), and more of them reported a history of hypertension 
(58% vs. 53%) compared to men. however, there were more men with carotid plaques 
(66% vs. 55%). In men, carotid intima media thickness was higher (1.1mm vs. 1.0mm), 
they smoked more (29% vs. 19%), and had a higher total cholesterol/hDL ratio (5.5 vs. 
5.1). The commonest oA sites in women were distal interphalangeal (DIP) joints (39%), 
carpometacarpal/trapezoscaphoid (CMC/TS) joints (33%) and knee joints (20%). In men, 
osteoarthritis in the distal interphalangeal (DIP) joints was commonest (25%), followed 
by carpometacarpal/trapezoscaphoid (CMC/TS) joints (19%). The prevalence of oA was 
significantly higher in women for all joint groups.
Table 1. Baseline characteristics of the study population.
variable All (n = 5650) Men (n = 2372) Women ( n = 3278)
Age, years 68.2 ± 8.0 67.5 ± 7.6 68.6 ± 8.3
Male, % 42
Body Mass Index, kg/m2 26.3 ± 3.6 25.7± 3.0 26.8 ± 4.0
Diabetes, % 10 10 10
Smoking, % 24 29 19
hypertension, % 56 53 58
Total cholesterol/hDL ratio 5.2 ± 1.6 5.5 ± 1.6 5.1 ± 1.6
Intima media thickness, mm 1.0 ± 0.2 1.1 ± 0.2 1.0 ± 0.2
Plaque present, % 59 66 55
Prevalence of oA
Knee, % 15 9 20
hip, % 6 5 7
DIP, % 33 25 39
PIP, % 12 9 16
MCP, % 5 4 7
CMC/TS, % 27 19 33
Categorical variables are presented as percentage. Continuous variables are expressed as mean ± 
SD.
oA = osteoarthritis; DIP = distal interphalangeal; PIP = proximal interphalangeal; MCP = metacar-
pophalangeal; CMC/TS = carpometacarpal/trapezoscaphoid
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Association of atherosclerosis with OA
Table 2 shows the association between IMT, carotid plaques and presence of knee and 
hip oA in the different models by gender. After full adjustment IMT showed an as-
sociation with prevalence of knee oA (fully adjusted odds ratio (aoR) 1.7 (1.1 - 2.7)) at a 
p-value <0.05 in women. Associations between IMT and carotid plaque with hand oA 
by gender are presented in Table 3. After full adjustment, carotid plaque showed an 
association with distal interphalangeal (DIP) oA (aoR 1.4 (1.2 - 1.7) and with metacarpo-
phalangeal (MCP) oA (aoR 1.5 (1.1 -2.2)) in women. no independent associations existed 
between measures of atherosclerosis and hip oA, PIP and CMC/TS oA. Comparison 
of the crude and adjusted models in Table 2 and Table 3 shows that the associations 
between IMT and plaque with presence of knee, hip, or hand oA are largely attenuated 
by age adjustment.
The relationship between vascular variables and overall progression of oA (Table 
4) showed a fully adjusted association between IMT and overall progression of MCP 
oA (aoR 2.9 (1.18 - 6.93) at a p-value of <0.05 in women. In men, no fully adjusted 
significant associations were observed between IMT or plaque and presence (Table 2 
and Table 3) or overall progression of oA (data not shown).
In a second step, we tested our results conservatively by using rigorous correction for 
multiple testing at p<0.0021 (a/24). This showed that the association between carotid 
plaque and DIP oA prevalence remained (aoR 1.4 (1.2 - 1.7)).
Table 2. Analysis of vascular variables in relation to the presence of knee oA and hip oA.
Men(n=2372) Crude Age adjusted Age+BMI adjusted Fully adjusteda
KneeoA IMT 2.5 (1.48 to 4.08)** 1.5 (0.82 to 2.64) 0.9 (0.62 to 1.18) 1.3 (0.68 to 2.36)
Plaque 1.0 (0.76 to 1.42) 1.2 (0.64 to 2.17) 0.9 (0.61 to 1.18) 0.9 (0.60 to 1.19)
hipoA IMT 1.5 (0.87 to 2.82) 1.0 (0.48 to 1.91) 0.9 (0.59 to 1.28) 1.0 (0.48 to 2.03)
Plaque 1.1 (0.73 to 1.58) 0.9 (0.44 to 1.85) 0.9 (0.60 to 1.31) 0.9 (0.70 to 1.63)
Women(n=3278)
KneeoA IMT 3.8 (2.54 to 5.52)*** 1.7 (1.10 to 2.52)* 1.7 (1.07 to 2.51)* 1.7 (1.10 to 2.73)*
Plaque 1.2 (1.02 to1.49)* 0.9 (0.77 to 1.15) 1.0 (0.79 to 1.19) 1.0 (0.81 to 1.24)
hipoA IMT 2.6 (1.59 to 4.38)** 1.3 (0.69 to 2.37) 1.3 (0.68 to 2.41) 1.4 (0.71 to 2.60)
Plaque 0.9 (0.73 to 1.26) 0.7 (0.54 to 0.99)* 0.7 (0.54 to 0.99) 0.8 (0.55 to 1.06)
unless otherwise indicated, values are odds ratios (95% CI)
IMT= intima media thickness, oA= osteoarthritis
aAdjusted for age, body mass index (BMI), diabetes, hypertension, cholesterol/hDL and smoking
*p<0.05 **p<0.01 ***p<0.001
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Discussion
In the present study independent correlations between measures of atherosclerosis 
with knee and hand oA prevalence were found in women after adjustment for cardio-
vascular risk factors. The same applied for progression of hand oA. In the next four 
subheadings we will discuss the most important findings.
Gender dif ferences
This study showed an independent association between atherosclerosis and oA of the 
DIP, MCP and knee joints in women, whereas this was not the case for men. Jonsson 
et al. previously demonstrated that hand oA and atherosclerosis were associated in 
older women [18] and hypothesized that circulatory disturbances in the synovial mem-
brane and subchondral bone might contribute to the cartilage destruction and to the 
pathophysiological process of osteoarthritis; we confirmed their results in this study. 
our results might indicate that due to hormonal changes during menopause, women 
are more at risk for developing vascular disease and oA. however, a systematic review 
Table 3. Analysis of vascular variables in relation to the presence of hand oA.
Men(n=2410) Crude Age adjusted Age+BMI adjusted Fully adjusteda
DIPoA IMT 1.7 (1.12 to 2.44) * 1.1 (0.73 to 1.70) 1.0 (0.65 to 1.51) 1.1 (0.67 to 1.64)
Plaque 1.0 (0.84 to 1.27) 0.9 (0.74 to 1.14) 0.9 (0.74 to 1.14) 1.0 (0.76 to 1.18)
PIPoA IMT 1.3 (0.78 to 2.23) 0.8 (0.45 to 1.52) 0.7 (0.39 to 1.35) 0.8 (0.40 to 1.40)
Plaque 1.0 (0.74 to 1.35) 0.9 (0.66 to 1.23) 0.9 (0.65 to 1.22) 0.9 (0.66 to 1.24)
MCPoA IMT 2.8 (1.61 to 5.00)*** 1.2 (0.56 to 2.47) 1.1 (0.51 to 2.25) 1.0 (0.46 to 2.06)
Plaque 1.6 (1.00 to 2.65)* 1.3 (0.79 to 2.18) 1.3 (0.79 to 2.16) 1.3 (0.78 to 1.80)
CMC/TSoA IMT 1.7 (1.13 to 2.63)* 0.9 (0.56 to 2.47) 0.9 (0.53 to 1.38) 0.9 (0.56 to 1.54)
Plaque 1.2 (0.98 to 1.56) 1.0 (0.80 to 1.29) 1.0 (0.79 to 1.27) 1.0 (0.78 to 1.28)
Women(n=3204)
DIPoA IMT 2.4 (1.68 to 3.42)*** 1.3 (0.89 to 1.91) 1.3 (0.85 to 1.83) 1.4 (0.93 to 2.10)
Plaque 1.5 (1.27 to 1.71)*** 1.3 (1.09 to 1.50)** 1.3 (1.10 to 1.52)** 1.4 (1.19 to 1.65)***
PIPoA IMT 2.9 (1.92 to 4.27)*** 1.5 (0.97 to 2.36) 1.5 (0.92 to 2.28) 1.3 (0.81 to 2.22)
Plaque 1.3 (1.06 to 1.59)* 1.1 (0.86 to 1.31) 1.1 (0.87 to 1.33) 1.1 (0.90 to 1.40)
MCPoA IMT 3.9 (2.38 to 6.40)*** 1.6 (0.88 to 2.78) 1.5 (0.81 to 2.67) 1.6 (0.84 to 2.94)
Plaque 2.0 (1.45 to 2.73)*** 1.5 (1.04 to 2.01)* 1.4 (1.04 to 2.00)* 1.5 (1.09 to 2.18)*
CMC/TSoA IMT 2.1 (1.45 to 3.00)*** 1.1 (0.72 to 1.63) 1.0 (0.86 to 1.22) 1.0 (0.68 to 1.59)
Plaque 1.2 (1.04 to 1.43)* 1.1 (0.71 to 1.62) 1.0 (0.86 to 1.22) 1.0 (0.88 to 1.24)
unless otherwise indicated, values are odds ratios (95% CI)
IMT= intima media thickness, oA= osteoarthritis,
aAdjusted for age, body mass index (BMI), diabetes, hypertension, total cholesterol/hDL and smok-
ing
*p<0.05 **p<0.01 ***p<0.001
Association between atherosclerosis and osteoarthritis 21
found no clear association between female hormonal aspects and oA [19]. Furthermore, 
effect modification by years since menopause was not present in our study. Recently, 
Gast el al.[20] showed that women with vasomotor menopausal symptoms are at risk 
for coronary heart disease. We studied a population of women aged ≥55 and detailed 
data on the perimenopausal period were not available. It is probable that the relation 
between menopause, atherosclerosis and oA is complex and cannot be shown in our 
study population. Younger perimenopausal women with early signs of oA manifest a 
greater metabolic component and research focussing on this group might elucidate 
why vascular disease and oA are associated in women, but not in men.
Knee OA, DIP OA and MCP OA
We showed associations between atherosclerosis and oA in several joints in women, 
but not with CMC oA or osteoarthritis of the hip. In the same way, Dahaghin et al 
[21] showed that BMI was associated with oA of DIP, PIP and MCP joints, but not with 
oA of the thumb base (CMCoA). CMC oA might be regarded a subset of hand oA and 
aetiologically different from DIP, PIP and MCP oA [22]. various studies support a differ-
ent pathogenesis between hip oA and knee oA as well [23-25]. Systemic factors such as 
disordered glucose metabolism, lipid metabolism and atherosclerosis, all related to the 
metabolic syndrome, seem to be more related to knee oA than hip oA. For example, 
BMI is highly associated with knee oA, but not or to a lesser degree with hip oA [23,24].
Table 4. Analysis of vascular variables in relation to the overall progression of oA in women.
no.of progressors (%) Crude Adjusted a
Progression Knee oA IMT 228 (19) 2.4 (1.19 to 5.00)* 1.9 (0.83 to 4.39)
Plaque 180 (18) 1.3 (0.98 to 1.66) 1.3 (0.97 to 1.67)
Progression hip oA IMT 131 (8) 0.9 (0.36 to 1.99) 0.5 (0.17 to 1.17)
Plaque 108 (8) 0.8 (0.59 to 1.11) 0.7 (0.53 to 1.02)
Progression DIP oA IMT 530 (47) 1.0 (0.54 to 1.85) 1.3 (0.65 to 2.66)
Plaque 445 (47) 1.0 (0.82 to 1.25) 1.1 (0.86 to 1.34)
Progression PIP oA IMT 292 (26) 0.6 (0.27 to 1.24) 0.6 (0.26 to 1.34)
Plaque 246 (26) 1.0 (0.75 to 1.21) 1.0 (0.77 to 1.29)
Progression MCP oA IMT 202 (18) 3.2 (1.49 to 6.87)** 2.9 (1.18 to 6.93)*
Plaque 158 (17) 1.0 (0.72 to 1.27) 0.9 (0.67 to 1.22)
Progression CMC/TS oA IMT 352 (31) 0.9 (0.44 to 1.77) 0.6 (0.25 to 1.27)
Plaque 285 (30) 1.0 (0.75 to 1.21) 0.9 (0.68 to 1.13)
unless otherwise indicated, values are odds ratios (95% CI).
oA= osteoarthritis, IMT= intima-media-thickness. DIP= distal interphalangeal, PIP= proximal inter-
phalangeal, MCP= metacarpophalangeal, CMC/TS= carpometacarpal/trapezioscaphoideal
a Adjusted for age, body mass index, diabetes mellitus, hypertension, total cholesterol/hDL, smok-
ing, months between baseline and follow-up visit and K&L score at baseline.
*p<0.05 **p<0.01
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Cardiometabolic disorders and OA
The metabolic syndrome is a multiplex cardiovascular risk factor. Besides atheroscle-
rosis, obesity, diabetes mellitus and dyslipidemia are listed as part of the metabolic 
syndrome. The main characteristic is the presence of systemic inflammation caused 
by visceral adipose tissue that secretes proinflammatory cytokines and adipokines [26]. 
These inflammatory processes are involved in the aetiopathogenesis of atherosclerosis, 
but also in rheumatic diseases such as psoriasis arthritis. There is increasing evidence 
that chronic systemic inflammation in patients with the metabolic syndrome might 
also initiate or stimulate the oA disease process [7]. We studied vascular variables that 
not only reflect generalized atherosclerosis, but are typically increased in individuals 
with the metabolic syndrome, or cardiometabolic disorders in general, as well [27,28]. 
Based on our results, osteoarthritis of the DIP joints may be linked to cardiometabolic 
disorders in women. Additional investigations to test this hypothesis are warranted.
Progression of OA
We noticed a tendency for an association between IMT and progression of MCP oA and 
knee oA in women. however, also indications for contradictory estimates were found 
for the association of vascular variables with overall progression of hip oA in women. 
We can’t give a clear explanation for these results, different relations between overall 
progression of knee and hip oA have been reported previously [15]. In addition, because 
the reasons for total hip replacements were not always clear, overall progression of hip 
oA remained a complex variable to analyze, although we adjusted for hip fractures as 
well. Furthermore, the very limited power for hip progression can give spurious results.
overall progression of osteoarthritis was defined as the combination of the incidence 
and the progression of existing oA at baseline [15]. When we analyzed incidence or 
progression separately as previously described in hands [29], or in knees and hips [25] 
we found similar results (data not shown). however, associations between vascular 
variables and incidence of knee oA in women were stronger than with true progression 
of knee oA. These results do not fully agree with the hypothesis proposed by Conaghan 
et al. [30] that by causing subchondral bone ischemia, atheromatous vascular disease 
contributes more to the progression of oA than to its initiation. The mechanism lead-
ing to the initiation and progression of oA still remains largely unknown [31].
Strengths and limitations
The major strength of this study is its size. We used a large population-cohort study, the 
Rotterdam Study, in which all relevant clinical and radiographic data were collected 
from a population at risk for osteoarthritis and cardiovascular disease. Detailed cardio-
vascular data, reflecting generalized atherosclerosis were available [10,11] and in the 
adjusted models we included potential confounders that could influence the associa-
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tion between atherosclerosis and osteoarthritis. Furthermore, we adjusted for baseline 
presence of osteoarthritis in our analyses of progression [16]. Due to the longitudinal 
nature of the Rotterdam study, we had the opportunity to analyze both prevalence and 
overall progression of oA.
Although our joint-specific analyses were hypothesis based, we tested our results 
conservatively by using rigorous adjustment for multiple testing in a second step. Some 
other hand joints as well as the knee joint showed effect estimates of similar magni-
tude in the same direction in both crude and adjusted analyses, but they did not reach 
statistical significance after these rigorous adjustments, possibly because of the lower 
prevalence of oA in these joints. Therefore we believe that our findings are supportive 
of an association between atherosclerosis and hand oA and knee oA in women, as 
found in previous studies [17,18].
The selection of our participants, based on the availability of radiographs, might 
have introduced a healthy-workers-effect, since these participants survived the follow-
up period and were fit enough to visit the research centre. We selected a younger and 
healthier sample and the incidence and progression of oA in these participants will 
be lower than in a population-based sample, so we can assume that if this healthy-
workers-effect would have influenced the associations we found, it would underes-
timate the true effect. In addition, data on overall progression of osteoarthritis was 
available for a small number of participants, which has limited our power to detect 
these associations. unfortunately, we did not have information on activity levels. As a 
result, residual confounding cannot be totally ruled out.
Future research
This study is the first large-scale prospective population-based cohort study that ad-
dresses the association between measures of atherosclerosis and oA. our study can 
therefore be viewed as one of the first steps to unravel the link between these two 
conditions. Many of the covariates are characteristics of a cardiovascular and metabolic 
profile [6,32,33]. The associations between measures of atherosclerosis and oA were 
highly driven by age and additional links seem to exist in certain joint types. We do 
not know which risk factors are specific for oA. We do know, however, that chronic 
inflammation plays an important role in both diseases. The accumulation of glycation 
end-products (AGes) in cartilage and arteries, or alternatively from oxidative stress 
in cartilage and arteries indicates a shared aetiology in vascular disease and oA [34]. 
however, additional replication in other studies is recommended and more detailed 
research is necessary to identify the exact underlying mechanisms for the association 
between cardiovascular disease and oA. A better understanding of how inflammatory 
activity in oA and atherosclerosis in women interacts with other recognized risk fac-
tors such as increasing age, menopause, diabetes and genetics might lead to improved 
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treatment strategies in women. In addition, reverse causation in which for example 
painful knee or hip oA leads to a sedentary life style and a cardiometabolic syndrome 
might exist.
Conclusions
This study showed independent associations of atherosclerosis with oA of the knee and 
hand joints in women. The evidence was most solid for a relation with DIP oA. More 
research is needed to confirm the associations and examine the differential association 
with various joints.
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Supplementary table S1. 
Definition of the Kellgren-Lawrence radiographic grades.
Grade Knee hip hand
0 no 
osteoarthritis
no features of 
osteoarthritis
no features of 
osteoarthritis
no features of 
osteoarthritis
1 Doubtful Doubtful narrowing 
of joint space and 
possible osteophytic 
lipping
Possible narrowing 
of joint space 
medially and possible 
osteophytes around 
the femoral head; or 
osteophytes alone
Minute osteophytes, 
doubtful significance
2 Mild Definite osteophytes 
and possible 
narrowing of joint 
space
Definite narrowing of 
joint space inferiorly, 
definite osteophytes, 
and slight sclerosis
Definite osteophytes, 
unimpaired joint space
3 Moderate Moderate multiple 
osteophytes, definite 
narrowing of joint 
space and some 
sclerosis and possible 
deformity of bone 
ends
Marked narrowing of 
joint space, definite 
osteophytes, some 
sclerosis and cyst 
formation, and 
deformity of the 
femoral head and 
acetabulum
Diminution of joint 
space
4 Severe Large osteophytes, 
marked narrowing 
of joint space, severe 
sclerosis and definite 
deformity of bone 
ends
Gross loss of joint space 
with sclerosis and cysts, 
marked deformity 
of femoral head and 
acetabulum and large 
osteophytes
Joint space impaired 
with sclerosis or 
subchondral bone
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Abstract
Objectives
Previous studies found an association between osteoarthritis (oA) and risk of cardio-
vascular disease (CvD) and therefore suggested intensive treatment of cardiovascular 
risk factors in oA patients. however, prospective population-based data is lacking. We 
investigated the association between oA and CvD longitudinally in a general popula-
tion and additionally examined the role of disability in this association.
Methods
This study was embedded in The Rotterdam Study, a prospective population-based 
cohort study in Rotterdam, the netherlands that started in 1989. At baseline 4,648 
persons aged ≥55, free of CvD were classified into those with and those without radio-
graphic or clinical oA. hazard ratios (hRs) adjusted for traditional cardiovascular risk 
factors for developing CvD (a composite of fatal and nonfatal coronary heart disease 
and stroke) were calculated.
Results
During a median follow-up of 14.4 years 1,230 cardiovascular events occurred, of which 
101 in the participants with clinical oA. Presence of radiographic oA at baseline was 
not related to future CvD (hR 0.99, 95%CI 0.86-1.15), neither was presence of clinical oA 
(hR 1.09, 95%CI 0.88-1.34). however, persons with increasing disability were more likely 
to suffer a cardiovascular event compared with non-disabled persons (hR 1.26, 95%CI 
1.12-1.42); this was independent of the presence of oA.
Conclusions
In this large population-based study, participants with oA were not at increased risk 
of CvD. The close relation between disability and osteoarthritis may explain previous 
findings. Further studies are required in order to clarify whether oA patients need 
more intensive treatment of their cardiovascular risk factors.
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Introduction
osteoarthritis (oA) is the most frequent joint disorder in the elderly and causes a 
considerable burden of pain, disability, and ever increasing costs to society [1]. Several 
cross-sectional [2, 3] and disease-specific mortality [4-6] studies suggest an association 
between oA and cardiovascular disease (CvD). The strongest body of evidence comes 
from a recent study comparing CvD mortality of selected oA patients with mortality 
statistics from the general population [6]. Therefore more intensive treatment of car-
diovascular risk factors has been proposed to prevent premature CvD in oA patients, 
similar to conditions like rheumatoid arthritis or gout [7-9]. Before implementing oA 
as another red flag into guidelines critical assessment of such claims are warranted, 
especially if robust prospective population-based comparisons are lacking.
Previous studies were hampered by methodological issues [6,10], such as small or 
selected patient groups, performed in occupational settings, or included reference 
groups based on data from national statistics. These study designs may thus be liable to 
mechanisms that increase the possibility of false positive results.
In the large ongoing Rotterdam Study, an unselected population, we studied the as-
sociation between various definitions of oA and long-term risk of CvD. We additionally 
examined the role of disability in explaining the apparent association between oA and 
CvD occurrence.
Methods
Study design, setting, and population
The Rotterdam Study is a prospective population-based cohort study that started in 
1990 to investigate the occurrence and determinants of diseases in a middle age and 
elderly population [11]. All 10,275 inhabitants aged 55 years and older who had been liv-
ing for at least 1 year in the ommoord district of the city of Rotterdam were invited to 
participate, of which 7,983 agreed. Trained interviewers obtained information at home 
on current health status, medical history, activities of daily living, joint complaints, 
and cardiovascular risk factors. Subsequently, all participants were invited to visit the 
research center for clinical examinations, laboratory assessments, and radiographs, 
regardless of their health status.
For this study, 1,428 participants with known CvD (defined as a history of myocardial 
infarction, surgical or percutaneous coronary revascularisation, or stroke) at baseline 
were excluded. Furthermore, 1,907 persons who either did not visit the research centre 
or had no radiographs taken due to logistic or technical problems were excluded, 
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which left us with a total population for analyses of 4,648 persons of whom we assessed 
CvD at follow-up.
All people provided written informed consent to participate in the Rotterdam Study 
and to obtain information from their treating physicians, separately. The study was 
approved by the medical ethics committee of the erasmus Medical Center, Rotterdam, 
the netherlands.
Assessment of OA
In total, 3 definitions of oA were formulated for knees, hips, and hands separately. 
The first one, radiographic oA (K&L graded score greater or equal to 2), as described 
in appendix 1. Secondly, we defined clinical oA as the presence of radiographic oA 
and reported complaints of the same joint in the last month. Finally, we analysed self-
reported oA (verified by trained interviewers; “Did you suffer from joint complaints 
last month which were attributed to oA by a physician?”) as a potential phenotype of 
oA. Since knee oA is highly prevalent and most clearly defined, we decided to show 
results with this phenotype in the analyses. however, we also analysed hand and hip 
oA, see Appendix 2.
Assessment of disability
For the assessment of disability the Stanford health Assessment Questionnaire (hAQ) 
was used [12]. The hAQ measures disability in eight fields (dressing and grooming, ris-
ing, reach, hygiene, eating, walking, grip and activity). each field comprises two to four 
items. Per item the status of the respondent is scored as able to do without difficulty 
(0), with some (1) or much (2) difficulty or unable to do with or without assistance (3). 
The highest item score determines the final field score. The mean score of all fields 
constitutes the disability index ranging from 0.00 to 3.00 [13]. In the present study we 
dichotomised disability as having any disability present in one of the eight fields versus 
none, irrespective of the presence of oA. In addition, we similarly analysed lower limb 
disability involving the fields rising and walking only. All values given in our analyses 
refer to the dichotomised disability variable.
Assessment of covariates
Data on medication use and smoking habits were obtained during the home interview. 
Smoking was classified as never, former, or current smoking. established cardiovascu-
lar risk factors were measured at the research centre. Body mass index was computed 
as weight divided by height squared. Blood pressure was measured at the right upper 
arm using a random-zero sphygmomanometer. We used the average of two measure-
ments measured on one occasion and defined hypertension as a systolic blood pressure 
of 140 mmhg higher, a diastolic blood pressure of 90 mmhg or higher, or the use 
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of blood pressure lowering medication for the indication of hypertension. Diabetes 
mellitus was defined as the use of antidiabetic medication or a non-fasting or post-load 
serum glucose level exceeding 11.0 mmol/L. Serum total cholesterol and high-density 
lipoprotein (hDL) cholesterol were determined by means of an automated enzymatic 
procedure in non-fasting blood samples.
Assessment of CVD
Persons were followed for the occurrence of a first coronary or cerebrovascular event, 
including myocardial infarction, surgical or percutaneous coronary revascularisations, 
coronary death, and stroke (both ischaemic and hemorrhagic) confirmed by one of the 
patients’ treating physicians. Methods of data collection and adjudication of events 
have been described previously in detail [14, 15]. In short, Rotterdam Study participants 
are followed-up continuously through direct digital linkage of the study base with 
medical files from the general practitioners working in the research area. Moreover, 
the entire medical record of each participant is checked on a regular basis for diagnoses 
of interest. All available information, such as discharge reports, eCGs, and neuroimag-
ing results are copied from the medical records or are obtained from the hospitals. 
Subsequently each potential CvD event is adjudicated according to standardised defini-
tions by two independent research physicians and either an experienced cardiologist 
or neurologist.
Statistical analysis
Baseline characteristics are summarized as percentages for categorical data. Continu-
ous data are presented as mean values and standard deviations.
We used eighteen Cox proportional hazard models to estimate the association be-
tween oA and risk of incident CvD. All models met the proportional hazards assump-
tion. In the first model, we estimated the association of radiographic knee oA with the 
occurrence of CvD adjusted for age and gender. In the second model, we additionally 
adjusted for the following cardiovascular risk factors: hypertension, smoking status, 
body mass index, diabetes, and total cholesterol to hDL-cholesterol ratio. Likewise, 
clinical knee oA, and self-reported oA were analysed as different phenotypes of oA. 
next, we checked whether there was evidence of effect modification by gender, since 
previous studies have described associations between oA and subclinical atheroscle-
rosis in women only [2, 16]. This was done by assessing the interaction terms between 
gender and oA status.
Since a recent study reported an association between walking disability and risk of 
CvD within oA patients [6] we ran similar Cox models as described above to estimate 
the association between overall disability and CvD and lower limb disability and CvD; 
this was done independent of the presence of oA. Last, in order to reduce the potential 
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diluting effects of misclassification of the outcome we performed a sensitivity analysis 
restricted to hard atherosclerotic CvD outcomes: myocardial infarction, ischaemic 
stroke, and coronary death.
Persons free of radiographic knee oA, free of clinical knee oA, and those without self-
reported oA were reference categories, respectively. All analyses were performed for 
hip oA and hand oA as well in an identical manner. Persons were censored at the date 
of noncoronary or noncerebrovascular death, loss to follow-up, or the end of the study 
period defined as the last date of follow-up. Approximately 1% of our study population 
had missing values for one or more cardiovascular covariates. These missing values 
were handled by single imputation using an expectation-maximisation algorithm [17]. 
All measures of association are presented with 95% confidence intervals. We used the 
level of significance of p<0.05 for all statistical analyses and the data were analysed 
using PASW statistical package, version 17.0.2 (SPSS Inc., Chicago, Ill., uSA).
Results
Characteristics of the study population
Baseline characteristics of the study population free of CvD at baseline are summarised 
in table 1. The mean age of the 4,648 persons in this study was 67.6 years, and 61% were 
women. During a median follow-up time of 14.4 years (interquartile range 7.6 years) a 
total of 1,230 CvD events occurred, of which 101 in the participants with clinical knee 
oA. These events consisted of 304 myocardial infarctions, 64 coronary artery bypass 
Table 1. Baseline characteristics of the study population.
variable All (n=4648) Knee oA* (n=336) hip oA* (n=134) hand oA* (n=339)
Age, years 67,6 ± 7,9 71,0 ± 8,2 72,0 ± 7,7 69,8 ± 7,6
Male gender, % 39 21 15 13
Body mass index, kg/m2 26,3 ± 3,6 28,2 ± 4,1 27,4 ± 3,9 27,2 ± 4,1
Cholesterol/hDL ratio 5,2 ± 1,6 5,1 ± 1,6 5,1 ± 1,5 5,1 ± 1,5
Diabetes, % 9 9 11 11
Current smoking, % 24 17 19 16
hypertension, % 53 63 55 61
Disability, % 57 85 90 75
Radiographic Knee oA†, % 21 100 19 53
Self-reported oA , % 18 56 63 19
Categorical variables are presented as percentages. Continuous variables are expressed as means 
and corresponding standard deviations. hDL = high density lipoprotein, oA = osteoarthritis
† Kellgren-Lawrence score ≥2 in at least one joint.
* Radiographic oA and reported complaints of the same joint during the last month.
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grafts, 69 percutaneous coronary interventions, 215 other fatal coronary heart disease 
events, and 578 strokes (of which 60 confirmed haemorrhagic). only 41 (<1%) persons 
were lost to follow-up.
Osteoarthritis and cardiovascular disease
The associations between oA of the knees and incident CvD are shown in table 2. After 
adjustment for age and gender, we found no association between radiographic knee 
oA and incident CvD (hR 0.99, CI 0.86 to 1.15), neither between clinical knee oA and 
CvD (hR 1.08, CI 0.88 to 1.33), or between self-reported oA and CvD (hR 1.08, CI 0.93 
to 1.24). Further adjustment for cardiovascular risk factors did not change the results. 
Interaction by gender could not be demonstrated (p=0.34) and the sensitivity analyses 
with hard CvD only did not alter the results. We performed identical analyses for hand 
and hip oA; the corresponding results are presented in appendix 2. Results for hand oA 
or hip oA were not different from those for knee oA.
Disability and cardiovascular disease
After adjustment for age and gender, disability was strongly associated with incident 
CvD (hR 1.30, CI 1.15 to 1.46). Full adjustment for body mass index, diabetes mellitus, 
hypertension, total cholesterol/hDL cholesterol ratio, and smoking slightly attenuated 
the association somewhat (hR 1.26, CI 1.12 to 1.42). Sensitivity analyses with lower limb 
disability only were not substantially different from overall disability. This is demon-
strated in table 3. Age and gender adjusted survival curves according to disability status, 
Table 2. Knee osteoarthritis and risk of incident cardiovascular disease.
hazard ratio (95%CI) P-value hazard ratio (95%CI) P-value
Total CvD (n=1230) hard CvD (n=889)
Radiographic oA† Model 1* 1.00 (0.87 to 1.15) 0.96 1.03 (0.88 to 1.21) 0.72
Model 2** 0.99 (0.86 to 1.15) 0.92 0.99 (0.84 to 1.17) 0.91
Clinical oA ‡ Model 1* 1.08 (0.88 to 1.33) 0.45 0.99 (0.77 to 1.28) 0.95
Model 2** 1.09 (0.88 to 1.34) 0.43 0.96 (0.75 to 1.24) 0.76
Self-reported oA Model 1* 1.08 (0.93 to 1.24) 0.32 1.07 (0.94 to 1.21) 0.33
Model 2** 1.09 (0.94 to 1.26) 0.26 1.09 (0.95 to 1.24) 0.24
CI = confidence interval, oA = osteoarthritis, CvD = cardiovascular disease
Total CvD = myocardial infarction, surgical or percutaneous coronary revascularisation, coronary 
mortality and stroke (ischaemic and hemorrhagic)
hard CvD = myocardial infarction, ischaemic stroke, and coronary mortality
† Kellgren-Lawrence score ≥2 in at least one joint, ‡Kellgren-Lawrence score ≥2 and complaints in 
the same joint during the last month
* adjusted for age and sex
** adjusted for age, sex, body mass index, diabetes, hypertension, total cholesterol/hDL cholesterol 
ratio, and smoking
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stratified on the presence of clinical knee oA, are shown in figures 1a and 1b. There 
was no evidence for interaction between disability and clinical knee oA status (p=0.89).
Discussion
In the present study, we examined the association of different phenotypes of oA with 
the long-term risk of CvD in a prospective population-based cohort. We showed that 
the presence of oA is not related to incident CvD in adults aged 55 years and older. 
however, overall and lower limb disabilities are risk factors for CvD, independent of 
oA status.
Table 3. Disability and risk of incident cardiovascular disease.
hazard ratio (95% CI) P-value hazard ratio (95% CI) P-value
    Total CvD (n=1230)   hard CvD (n=889)  
Disability Model 1* 1.30 (1.15 to 1.46) <0.001 1.29 (1.12 to 1.49) 0.001
  Model 2** 1.26 (1.12 to 1.42) <0.001 1.22 (1.06 to 1.41) 0.007
LL disability Model 1* 1.22 (1.08 to 1.38) 0.002 1.26 (1.09 to 1.45) 0.002
  Model 2** 1.19 (1.05 to 1.34) 0.008 1.18 (1.02 to 1.37) 0.03
CI = confidence interval, CvD = cardiovascular disease, LL = lower limb.
Total CvD = myocardial infarction, surgical or percutaneous coronary revascularisation, coronary 
mortality and stroke (ischaemic and hemorrhagic)
hard CvD = myocardial infarction, ischaemic stroke, and coronary mortality.
* adjusted for age and sex
** adjusted for age, sex, body mass index, diabetes, hypertension, total cholesterol/hDL cholesterol 
ratio, and smoking
Figure 1. Age and gender adjusted CvD-free survival curves for non-disabled and disabled partici-
pants in A) participants with clinical knee oA, and B) participants free of clinical knee oA.
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Context
our study was prompted by the recent report by nüesch et al [6] who found that oA 
patients were at higher risk of cardiovascular death compared with their age and gen-
der matched peers. This study was performed in a group of oA patients compared to 
national statistics where data on covariates were not available. As a result, they could 
not correct for significant confounding variables such as comorbidities or disability. 
Furthermore, selection of diseased patients into their study may have led to inflated 
estimates. This is referred to as the sick-person-effect [18].
We used a population-based cohort with detailed data on cardiovascular covariates 
and disability, also for persons without oA, and were thereby able to provide a less 
biased estimate of the association. Given that we did not find an association between 
several phenotypes of oA and cardiovascular endpoints in our study population, we 
also investigated other phenotypes. When we analysed summed K&L scores of the 
knees, hands or hips separately or included all total joint replacements due to oA 
as markers of severity of oA the results did not alter. This was also the case when 
we compared participants with generalized oA (at least two out of three joint groups 
affected) to participants without any oA. Moreover, the association of oA with the 
various components of the composite CvD outcome (coronary heart disease and stroke) 
analysed separately did not change our results (data not shown). In the present study 
disability – defined by the hAQ questionnaire – strongly predicted CvD independent 
of clinical oA status. our results therefore support the view that disability, and not 
oA, predicts CvD [19]. Disability might represent a marker of the general health status 
rather than a representation of specific underlying chronic diseases such as oA. Fur-
ther studies are needed to investigate whether hAQ disability contributes to improved 
cardiovascular risk stratification in the population at large and to identify underlying 
causes of disability in order to ameliorate excess cardiovascular risk.
Implications
The relation between oA and increased risk of future CvD mortality, as found by 
nuesch et al suggested intensive treatment of cardiovascular risk factors in oA pa-
tients [6]. Before implementing oA as another red flag into CvD prevention guidelines, 
we considered it necessary to critically assess this claim in a robust population-based 
study. In contrast to nuesch et al, we excluded persons with known CvD at baseline to 
investigate whether oA patients were at high risk of CvD. We demonstrated that oA is 
not an independent risk factor for the development of incident CvD in a population-
based setting.
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Strengths and limitations
The major strengths of the present study are its vast size, the long-term highly detailed 
follow-up, the community-based setting, and moreover the use of an internal reference 
population for comparing people with oA to those free of oA. A substantial number of 
people with oA – defined both by radiographs, and by symptoms – were included and 
the median follow-up time was 14.4 years.
however, residual confounding has to be considered. As we did not measure physi-
cal fitness and had no reliable information on medication use without a prescription, 
additional confounders might exist. In addition, participation bias, occurring in all 
studies requiring active participation, may have influenced our results.
The main aim of this study was to investigate whether physicians should consider 
oA patients at high risk of CvD. our study population comprised persons aged 55 
years and older and we were thereby unable to look into the association between oA 
and CvD in younger individuals. A cardiometabolic phenotype of oA [20] in younger 
women characterized by low-grade inflammation by visceral adipose tissue [21] might 
exist. Although both conditions share aetiological features [3, 16] and risk factors, we 
did not focus on a common pathophysiology by investigating subclinical measures of 
atherosclerosis. This complex and promising field of research merits further elucida-
tion and will be investigated in depth in future studies with currently gathered data 
from younger women [11].
Conclusions
In this population-based study, persons with oA were not at increased risk of develop-
ing CvD compared to those without oA. The close relation between disability and oA 
may explain earlier findings of a relation between oA and risk of CvD. Further studies 
are required to clarify whether younger oA patients than in the present study benefit 
from more intensive treatment of their cardiovascular risk factors.
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Appendix 1.
Knee, hand, and hip radiographs were taken and scored with a Kellgren-Lawrence 
grade scaled 0-4. Radiographs of the pelvis were obtained with both feet rotated 10° 
inward and the X-ray beam centred on the umbilicus and knee radiographs were taken 
with the knee extended and the patella in a central position. Assessment was done 
blinded for clinical data. The intraclass correlation coefficient was 0.71 for the knee and 
0.74 for the hip [16,22,23]. Radiographic knee and hip oA were defined as a K&L score of 
2 or higher present in at least one joint. Persons with total joint replacements (knees; 
n=10, hips; n=113) at baseline were excluded from the analyses. The hand joints were 
divided into distal interphalangeal (DIP), proximal interphalangeal (PIP), and first car-
pometacarpal/trapezioscaphoid (CMC1/TS, base of thumb) joint groups where oA was 
considered present if at least one joint of the group scored a K&L grade of 2 or higher. 
Radiographic hand oA was defined according to the Rotterdam definition: present if at 
least 2 out of 3 hand joint groups (DIP/PIP/CMC1 or TS) had a K&L score of 2 or higher 
in at least one hand [24]. For the handjoints the intraclass correlation coefficient was as 
follows: DIPs; 0.69, PIPs; 0.74, CMC1/TS (base of thumb); 0.84.
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Appendix 2.
hand osteoarthritis and risk of incident cardiovascular disease.
hazard ratio (95% CI) hazard ratio (95% CI)
Total CvD (n=1239) hard CvD (n=804)
Radiographic oA † Model 1* 0.91 (0.80 to 1.03) 0.97 (0.83 to 1.13)
Model 2** 0.93 (0.82 to 1.06) 0.97 (0.83 to 1.14)
Clinical oA ‡ Model 1* 1.04 (0.84 to 1.29) 1.22 (0.94 to 1.57)
Model 2** 1.08 (0.87 to 1.34) 1.25 (0.97 to 1.61)
Self reported oA Model 1* 1.08 (0.94 to 1.25) 1.09 (0.91 to 1.31)
Model 2** 1.09 (0.94 to 1.26) 1.08 (0.90 to 1.30)
CI = confidence interval, oA = osteoarthritis, CvD = cardiovascular disease
Total CvD = myocardial infarction, surgical or percutaneous coronary revascularisation, coronary 
mortality and stroke (ischaemic and haemorrhagic)
hard CvD = myocardial infarction, ischaemic stroke, and coronary mortality.
*adjusted for age and sex
** adjusted for age, sex, body mass index, diabetes, hypertension, total cholesterol/hDL cholesterol 
ratio, and smoking
† At least 2 out of 3 hand joint groups Kellgren-Lawrence score ≥ 2 in at least one hand
‡ At least 2 out of 3 hand joint groups Kellgren-Lawrence score ≥ 2 in at least one hand, and joint 
complaints
hip osteoarthritis and risk of incident cardiovascular disease.
hazard ratio (95% CI) hazard ratio (95% CI)
Total CvD (n=1172) hard CvD (n=745)
Radiographic oA † Model 1* 0.98 (0.79 to 1.22) 0.93 (0.70 to 1.22)
Model 2** 0.97 (0.77 to 1.21) 0.91 (0.69 to 1.21)
Clinical oA ‡ Model 1* 1.03 (0.67 to 1.58) 1.04 (0.61 to 1.76)
Model 2** 1.01 (0.65 to 1.57) 1.10 (0.65 to 1.87)
Self reported oA Model 1* 1.09 (0.94 to 1.27) 1.13 (0.94 to 1.36)
Model 2** 1.08 (0.93 to 1.26) 1.11 (0.92 to 1.34)
CI = confidence interval, oA = osteoarthritis, CvD = cardiovascular disease
Total CvD = myocardial infarction, surgical or percutaneous coronary revascularisation, coronary 
mortality and stroke (ischaemic and haemorrhagic)
hard CvD = myocardial infarction, ischaemic stroke, and coronary mortality.
* adjusted for age and sex
** adjusted for age, sex, body mass index, diabetes, hypertension, total cholesterol/hDL cholesterol 
ratio, and smoking
† Kellgren-Lawrence score ≥2 in at least one side
‡ Kellgren-Lawrence score ≥2 and joint complaints during the last month
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Introduction
The objective of this thesis was to gain insight into the relation between vascular 
pathology and osteoarthritis (oA). We could not show an association between athero-
sclerosis and the incidence or progression of oA and could therefore not confirm an 
initiating role for atherosclerosis in the development of oA. Furthermore, oA was not 
a risk factor for incident cardiovascular disease. on the other hand, atherosclerosis 
was associated with prevalent oA of the knee and hand joints among women. Also, 
plasma levels of biomarkers of early atherosclerosis (CD40L and vCAM-1) were higher 
in women with knee oA than in those without. The same did not hold for men. These 
findings are in line with the hypothesis that atherosclerosis and oA are concurrent 
diseases with a shared aetiology, possibly systemic low-grade inflammation, among 
women. In this chapter, I first summarize and review the main findings in the context 
of current knowledge. Because additional cardiovascular risk factors might confound 
the association between atherosclerosis and oA, the focus will also be on a common 
precursor of cardiovascular risk factors, namely obesity, in relation to oA. next, meth-
odological issues are discussed and finally I will reflect on the clinical implications of 
the reported studies and make suggestions for possible directions of future research.
Atherosclerosis, hand OA and knee OA
In the Rotterdam Study, we found cross-sectional associations between carotid ath-
erosclerosis and knee and hand oA among women aged ≥55 years, after adjustment 
for potential confounders (chapter 2). The evidence was most solid for a relation with 
distal interphalangeal (DIP) oA of the hands. Several other studies have found associa-
tions between subclinical measures of atherosclerosis and oA, suggesting either a local 
effect, a systemic effect, or both.1-4
A possible systemic effect is most pronounced in the aetiology of hand oA. Saleh 
et al.1 previously reported a relation between arterial stiffness and hand oA that was 
largely confounded by age. In addition, Jonsson and colleagues2 demonstrated that 
atherosclerosis and oA of this non-weight bearing joint were associated among older 
women (mean age 76 years); both carotid plaques and coronary artery calcifications 
showed a linear trend with hand oA severity. Analyses were adjusted for age, body 
mass index (BMI) and other cardiovascular risk factors. These findings were confirmed 
in another large cohort among elderly women (mean age 69 years) in chapter 2. More-
over, oA in any finger joint predicted cardiovascular death in a Finnish study.5
It is remarkable that an association between atherosclerosis and hand oA is mainly 
found among older women. Assuming that this relation exists based on the evidence 
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described above, what underlying mechanism is most probable? In menopause, pro-
duction of estrogen diminishes and the incidence of both cardiovascular disease and 
oA rises faster compared to men in the same age-bracket.6-9 The menopausal transition 
also induces a rapid increase in fat mass and redistribution of fat to the abdomen.10 Fur-
thermore, women generally have a higher fat percentage and more fatmass compared 
to men.11 Possibly, an inflammatory effect of adipose tissue, also known as metabolic 
syndrome, contributes to the development of both atherosclerosis and hand oA among 
women.12 It is known that adipose tissue is not inert and actively contributes to systemic 
inflammation through the secretion of inflammatory cells; abdominal fat especially is 
believed to act as an inflammatory mediator.13,14 however, additional investigation is 
warranted to test this hypothesis. Whether similar mechanisms play a role in men 
remains to be determined. Also, genetics and residual confounding cannot be ruled 
out in the apparent association between atherosclerosis and hand oA among women. 
These issues will be further discussed in the methodological considerations paragraph.
Previous studies on atherosclerosis and knee oA are inconclusive. Reported asso-
ciations are consistent neither for different measures of atherosclerosis, nor for early 
features of knee oA. For instance, Davies-Tuck et al.3 found that increased retinal vas-
cular diameters were associated with early features of knee oA detected with magnetic 
resonance imaging (MRI) among 289 women with no knee symptoms. Analyses were 
adjusted for age and BMI. By contrast, no association was reported between aortic 
stiffness and bone marrow lesions (early features of knee oA) among 208 individu-
als with symptomatic knee oA.15 Also, we could not show a relation between carotid 
atherosclerosis and similar signs of early knee oA (chapter 4). our study population 
and methodology were similar to the study that investigated the retinal vasculature. 
We don’t have a clear explanation for these discrepancies. Microvascular pathology 
(as reflected in the retina) might be more important in the pathogenesis of knee oA 
than large artery atherosclerosis. visual impairments and oA are indeed a common 
comorbid pair.16 Studies focused on the retinal vasculature as a reflection of oA activity 
are therefore needed.
Interestingly, recent studies showed that a local effect of atherosclerosis might 
contribute to development of knee oA. Increased popliteal arterial wall thickness 
was associated with symptomatic knee oA4 and predicted adverse changes in knee 
structure (reduced medial tibial cartilage volume and BML deterioration) two years 
later in a population without clinical knee oA (n = 254). It remains unclear whether 
increased wall thickness of the popliteal artery near the knee is a localized or gener-
alized medium-sized artery phenomenon. Locally, a reduced blood flow by popliteal 
atherosclerosis near the knee might affect the subchondral bone, thereby initiating the 
knee oA disease process. Yet, a recent study found no reduced blood flow in the main 
vessels supplying the knee joints in 39 female bilateral knee oA patients compared 
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to 30 healthy controls.17 unfortunately, oA patients with hypertension and diabetes 
were excluded, and knee oA was defined through radiographs. Additional longitudinal 
studies are warranted to examine a possible causal effect of local atherosclerosis on 
knee oA development.
To summarize, our findings suggest that systemic processes associated with athero-
sclerosis contribute most in the aetiology of hand oA.18 Regarding knee oA, we found 
less evidence for a systemic effect. Similar differences in the contribution of systemic 
processes associated with atherosclerosis to oA development of non-weight bearing 
and weight-bearing joints have been reported in other large cohorts as well.19,20
Possible pathways between atherosclerosis and OA
Generalized atherosclerosis (as measured in the carotids, coronary arteries and by 
serum markers) was not associated with the initiation or progression of oA of the 
hands, knees, or hips (chapter 2 and 3). We therefore did not find evidence to support 
the theory that atherosclerosis precedes oA. The studies in this thesis are the first 
large-scale prospective population-based cohort studies that address the association 
between different measures of atherosclerosis and the initiation or progression of oA 
and can therefore be viewed as one of the first steps to uncover the link between these 
two conditions. unfortunately, the power to analyse  progression of oA was limited 
and definitions of the incidence and progression of oA were based on radiographs 
that might be unable to detect subtle structural changes within the joints involved. In 
addition, we did not investigate the thickness of the popliteal artery wall.
In the course of the last decade, several theories on how atherosclerosis contributes 
to oA have been postulated. We will shortly highlight two hypotheses and add a third 
one, focused on knee oA.
Possibly, atheromatous disease of the artery disturbs cartilage homeostasis by a re-
duced blood flow to the synovial membrane and subchondral bone, thereby initiating 
the oA process2,21, as shortly mentioned above with regard to the popliteal artery and 
knee oA. This might occur through mechanical changes of the subchondral bone or 
pro-inflammatory cells that mediate degradation of the cartilage. Alternatively, the oA 
disease process could be accelerated instead of initiated by atheromatous disease. It 
could alter the subchondral bone through direct ischaemic effects (e.g. bone marrow 
edema). histologically, bone marrow edema is an area of necrosis and remodeling22 
and may represent ischaemic areas in the bone similar to those in avascular necrosis.23 
Bone marrow edema in the subchondral bone strongly predicts knee oA progres-
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sion.24-26 hence, atherosclerosis could be more important in the progression to severe 
joint damage than in the initiation of oA.27
We hypothesize that a local effect of adipokines secreted by adipose tissue28,29 adds 
to the influence of atherosclerosis on knee oA. Among women, painful knees (early 
signs of knee oA) are related to a greater inter-muscular fat mass in the thighs. An 
additional tissue could therefore be involved in the initiation or progression of knee 
oA, namely adipose tissue in the thigh. We theorize that a cumulative effect of local 
adipokines30 released by the fat mass in the thigh (and possibly also the infrapatellar 
fat pad) exists that deteriorates the knee joint. on a molecular level, adipokines are 
capable of modulating cross-talk between T-cells and chondrocytes.
however, all these complex theories remain speculative. hitherto, observational 
studies have focussed on atherosclerosis and early features of knee oA and were 
mainly cross-sectional in design. Additional longitudinal and experimental studies are 
needed to elucidate if and how atherosclerosis and adipose tissue localized near the 
knee contribute to knee oA development. Also, whether the mechanisms described 
play a role in hand or hip oA development remains to be determined. Longitudinal 
magnetic resonance imaging (MRI) knee data from the Rotterdam Study with detailed 
information on structures involved in KoA development will become available in the 
next year and might offer additional insights on the role of atherosclerosis and adipose 
tissue surrounding the knee as initiators or progressors of knee oA.
The role of obesity
Both vascular atheromatous disease and oA are slow progressive disorders that co-occur 
with many other chronic conditions, which makes their mutual relation complex to 
analyze and easy to confound. For instance, cardiovascular risk factors such as hyper-
tension, dyslipidemia, and increased glucose levels might influence both atheroscle-
rosis and oA separately. Furthermore, it is not known how these risk factors interact, 
neither for the initiation, nor for the progression of the oA disease process. For these 
reasons and because we found evidence for a relation between atherosclerosis and oA 
that can be explained by a common underlying effect of adipose tissue, we will now 
shortly focus on the common precursor of cardiovascular risk factors, namely obesity, 
in relation to oA.
obesity influences the development of oA in various ways. Being overweight obviously 
increases mechanical forces across weight-bearing joints.31,32 In addition to loading, 
systemic factors associated with obesity also play a role.33 Adipose tissue secretes in-
flammatory mediators (adipokines) that might increase the incidence and progression 
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of oA.34 Mainly visceral fat seems to be important in this process. A strong body of 
evidence has demonstrated a relation between obesity and hand oA35,36, thereby sug-
gesting that systemic factors associated with obesity are involved in the development 
of oA; after all, ‘obese people do not walk on their hands’.37 An excess of adipose tissue 
might cause a state of permanent low-grade, systemic infl ammation13, also known as 
metabolic syndrome. Biochemically, the main characteristic of metabolic syndrome is a 
systemic infl ammation caused by visceral adipose tissue that secretes proinfl ammatory 
cytokines and adipokines.14 In clinical practice, metabolic syndrome can be seen as a 
multiplex cardiovascular risk factor including obesity, diabetes mellitus, hypertension, 
and dyslipidemia. however, it is unknown whether the concept of a clinical syndrome 
improves individual cardiovascular risk prediction compared to independent cardio-
vascular risk factors; a potential accumulative effect of the components of metabolic 
syndrome remains an area of debate.
Figure 1 schematically highlights obesity in relation to several known and lesser-
known processes that are involved in oA development. I focus on the grey rectangle, 
but it might be clinically relevant to study areas such as pain and comorbidity in rela-
tion to oA development as well.
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Figure 1. Simplifi ed model of pathways involved in oA pathogenesis. The fi gure is a modifi cation of 
the schematic representation of relations between environmental and endogenous risk factors for 
oA and its consequences as proposed by Dieppe and Lohmander. (see general introduction, fi gure 2)
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A metabolic OA phenotype?
As visualized in figure 1, oA is a complex multifactorial disease that can be seen as a 
final common pathway to many predisposing factors, age, gender, genetics, trauma, 
and mechanical load being the key ones. Anything that can be intervened with within 
these pathophysiological processes is a potential phenotype of oA. In one individual, 
several different oA phenotypes might co-exist and interact, which complicates this 
area of research. Therefore, observational studies probably cannot prove phenotypes 
of oA. nonetheless, suggestions for phenotypes of oA have increased in number in the 
last decade38-41 and have led to an intense debate. This is understandable, because every 
phenotype is a potential target for randomized clinical trials40 and is in essence thera-
peutically different. no disease-modifying treatment for any subgroup of oA exists just 
yet. We attempt to add to the discussion by proposing a combination of a joint-based 
and pathophysiology-based model.
It is well-known that knee oA is a strong predictor for hand oA42,43 and vice versa.44 
They share several risk factors, and inflammatory mediators (adipokines) released by 
adipose tissue might influence both phenotypes36,45,46, albeit more pronounced in hand 
oA. Based on a review of the scientific literature of the last 5 years, a clinical oA phe-
notype was proposed recently among obese women aged 45-65 years affecting mainly 
hand and knee joints.41 In the Rotterdam Study, atherosclerosis and oA of the hand 
and knee joints were also associated among women (mean age 68.6 years) (chapter 
2), which supports the proposed metabolic phenotype. Among middle-aged women 
similar measures of generalized atherosclerosis were not associated with early features 
of knee oA (chapter 4), but the power was limited.
Taken together, there is evidence suggesting a clinical metabolic oA phenotype of 
the hand and knee joints that might be restricted to women. Inflammatory mediators 
released by adipose tissue could be a specific therapeutic target, next to weight loss.41 
Although this potential phenotype is not yet fully characterized, it might provide a 
starting point for further research and discussion. oA pathogenesis might proceed via 
unique gender-specified pathways based on underlying hormonal and anatomic differ-
ences. In our search for a better understanding of metabolic contributions to oA, it is 
important to evaluate potential gender-differences.47 Particularly the metabolic effects 
of menopause deserve more attention.
Menopause
In menopause, production of estrogen diminishes and the incidence of both cardio-
vascular disease and oA rises faster compared to men in the same age-bracket.6-9 This 
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sudden increase might be due to the loss of a protective effect of estrogen. however, 
in a large prospective cohort study hormone replacement therapy did not improve 
cardiovascular outcome in postmenopausal women.48 In addition, a recent systematic 
review found no clear association between female hormonal aspects and the develop-
ment of oA.49 Investigations of hormonal aspects of menopause are complicated by the 
production of estrogen by body fat and the fact that estrogen levels in premenopausal 
women change almost daily. Maybe, the role of female hormones is more complex than 
can be shown by population-based association studies.
unfortunately, in vivo and in vitro studies on female hormones and oA add to this 
complexity. A systematic review showed considerable evidence for a relation between 
ovariectomy (female hormone depletion) and cartilage degeneration in mature 
animals.50 however, evidence for the effect of estrogen suppletion on cartilage and 
subchondral bone was inconclusive or conflicting. For example, intra-articular high-
dose estradiol injections administered to rabbits led to detrimental effects on cartilage 
tissue51, whereas in ovariectomized mice estradiol injections had a beneficial effect on 
cartilage and subchondral cortical thinning.52 Such discrepancies might be due to large 
variations in experimental setup, but also reflect the difficulties in epidemiological and 
experimental research focused on estrogens and oA. estrogens affect numerous articu-
lar tissues in the human body through direct and indirect mechanisms that are not 
fully understood.53,54 Several reviews suggest that estrogens have the ability to interact 
with known and unknown inflammatory cytokines released by chondrocytes, and that 
next to estrogen receptor (eR) upregulation other processes (free radical scavengers) 
can be involved in estradiol-induced cartilage damage.55
With regard to the pathway between estrogens, menopause and cardiovascular 
disease, questions remain as well. on a molecular level, estrogens might reduce ath-
erosclerosis by binding to estrogen receptors (eR). Mainly eRa seems to be important in 
altering gene expression and thereby vascular cell function. eRa expression is strongly 
related to endothelial dilatation and is reported to be more than 30% lower in post-
menopausal women than in premenopausal women.56 however, many aspects of these 
complex signaling eR pathways remain unknown and they are strongly influenced 
by disease and age.57 on a population level, Gast et al.58 recently demonstrated that 
women with menopausal symptoms (night sweats) have an increased risk of coronary 
heart disease, which cannot be totally explained by the levels of cardiovascular risk 
factors. Furthermore, data from the Framingham heart Study suggest that a harmful 
cardiovascular risk profile may be more cause than consequence of age at menopause.
The pathway between menopause, cardiovascular disease, and osteoarthritis seems 
to be highly complex and much remains to be discovered.
98 Chapter 7
It is possible that the risks imposed by menopause, metabolic syndrome and atheroscle-
rosis somehow depend on each other, which might explain some of the complexities in 
oA aetiology that are not well understood. A study also analyzing data from the large 
Rotterdam cohort suggests that menopause as a risk factor for oA depends on body 
mass index. Menopause was related to both osteophytes and bone marrow lesions, 
but only among obese women (de Klerk, preliminary data). Following this reasoning, 
menopausal status might act as a moderator of the influence of metabolic syndrome on 
the development of oA. Alternatively, menopausal status could influence oA indirectly, 
by influencing metabolic syndrome (figure 2). Whether similar mechanisms hold true 
for the thickness of the arteries above a certain cut-off remains to be determined.
In summary, atherosclerosis, metabolic syndrome, menopause and oA are all slow 
and complex processes that are prone to interacting factors. The pathway of atheroscle-
rosis (or metabolic syndrome) to oA and the moderating effect of menopause herein 
merit further research.
Methodological considerations
All studies described in this thesis were part of the Rotterdam Study, a prospective pop-
ulation-based study.59 unfortunately, population-based studies are scarce worldwide, 
probably due to high costs (large sample sizes, many measurements and long follow-up 
periods) and logistical challenges. Yet, I advocate conducting population-based cohort 
studies with clinical outcome measures. They provide a wide range of exposure-disease 
associations in an unselected population. Another advantage is the external validity – 
that is, the applicability of results to a defined population.60
observational studies such as the Rotterdam Study are used to study the incidence 
and causes of disease. The ‘ommoord cohort’, comprising a huge data set of an adult 
Metabolic 
syndrome OA
Menopause
Atherosclerosis
?
?
?
Figure 2. Schematic representation of the complex relation between metabolic syndrome, athero-
sclerosis, menopause and oA. Arrows indicate causal pathways.
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population with prospective data on, among others, measurements of atherosclerosis 
(including both imaging and serum markers), features of local and widespread oA 
(radiographic imaging, MRI), and potential confounders over a ten-year period, has 
given us the opportunity to investigate the mechanism of action of vascular pathology 
in oA. however, cohort studies may be subject to data dredging and bias.61 Although we 
have tried to minimize these issues by high response rates, minimal loss to follow-up, 
pre-defined hypotheses, and adjustment for known confounders, bias can never be 
totally ruled out. For instance, there are many serum markers of atherosclerosis; which 
ones reflect atherosclerosis best remains area of debate. originally, we planned to look 
at von Willebrandfactor as a serum marker of atherosclerosis as well. however, based 
on discussions with experts in cardiovascular epidemiology and a consultation of the 
scientific literature62,63 we chose vascular cell adhesion molecule, CD40 ligand, and 
vascular endothelial growth factor.
Karasik et al.64 showed in the Framingham heart Study that hand osteophytes were 
not associated with abdominal aortic calcification, after adjustment for age, sex, body 
mass index, smoking, alcohol consumption, physical activity, systolic blood pressure, 
total cholesterol level, diabetes, and estrogen replacement therapy. unfortunately, we 
did not have reliable information on activity levels and were unable to adjust for this 
potential confounder. Being physically inactive is a key risk factor for oA, disability, 
and cardiovascular disease and might thus be a significant “hidden” confounder that 
explains the association found between atherosclerosis and oA. In addition, vascular 
pathology and osteoarthritis are slow and complex disorders, often accompanied by 
other diseases.65,66 Analyses are always complicated by bio-psychosocial factors includ-
ing lifestyle and mental health (residual confounding). Residual confounding also ham-
pered the interpretation of classical epidemiological methods in this thesis (chapters 
2, 3, and 4).
In a Mendelian randomization study, we therefore investigated whether genetically 
defined elevated levels of glycemic traits were associated with the presence of oA of 
the knee, hip and hand (chapter 5). The random assortment of alleles at the time of 
gamete formation results in population distributions of genetic variants that are gener-
ally independent of behavioral factors that confound epidemiological associations.67 
Single nucleotide polymorphisms (SnPs) that are genome-wide significant are used to 
construct genetic risk scores (GRS) for chronic diseases such as diabetes and oA. In 
other words, GRS identify persons at increased risk for a chronic disease based on 
their genetic profile. In contrast to atherosclerosis and oA, many SnPs are known for 
glycemic traits with moderate to large effect sizes. In our case, we chose genetically 
defined elevated glucose levels, but other components of the metabolic syndrome, such 
as higher cholesterol levels, could be another field of research.  A recent study using a 
similar Mendelian randomisation approach clearly showed that body mass index plays 
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a causal role in the development of oA. It might also identify other independent risk 
factors for oA and provide further insights into the biological processes that underlie 
oA susceptibility.68
Generalized estimating equations (Gee), taking into account both extremities, were 
used to adjust for correlations between the right and left extremity in each individual 
and to increase discriminative ability (chapter 2, 3, and 4). however, atherosclerosis 
is most likely a systemic condition and adjustment for the correlation between both 
extremities might not be essential and could theoretically distort the association. 
We therefore also constructed several logistic regression models on a person level to 
provide additional insight into how the link between atherosclerosis and oA might be 
driven. These models showed similar results as the Gee models. Because Gee increases 
power and discriminative ability, we prefer Gee-based analyses in oA research.
In a mediation analysis (Sobel-test) we found that oA precedes disability (chapter 6). 
This is not new evidence69, but studying if and how oA causes disability remains a chal-
lenge.70 There are other chronic diseases that co-exist with oA and that might cause 
disability.71,72 (figure 3). Interestingly, Reeuwijk et al73 recently investigated which 
co-existing disorders are disabling among hip or knee oA patients in order to eventu-
ally develop functional exercise therapy. They found that chronic back pain, diabetes, 
hearing impairment, visual impairment, dizziness in combination with falling, hand 
oA, and especially being overweight, were associated with disability. unfortunately, 
oA patients were recruited from hospitals and rehabilitation centers.  It might be 
worthwhile to start a similar study in a general population suffering from oA as well. 
Questionnaires or medical record review could be used to determine comorbidities, 
disability and for instance pain.
OA
Disability
Cardiovascular 
disease
Comorbidities
Figure 3. Schematic representation of the relation between oA, disability, and cardiovascular dis-
ease. Arrows indicate causal pathways.
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Clinical implications
The main objective of Chapter 6 was to investigate whether physicians should consider 
oA patients at high risk of cardiovascular disease (CvD). Before including oA as another 
red flag in CvD prevention guidelines similar to conditions such as rheumatoid arthri-
tis or gout74,75, as proposed by the British Medical Journal76,77, we considered it necessary 
to critically assess this claim in a robust population-based study. In contrast to previous 
studies, we excluded persons with known CvD at baseline to investigate whether oA 
patients were at high risk of CvD. We demonstrated that oA is not an independent 
risk factor for the development of incident CvD in a population-based setting. our 
recommendation is therefore not to include oA into CvD prevention guidelines.
Disability, however, was a risk factor for CvD, independent of oA status. even mini-
mal activity limitations as defined by the Stanford health Assessment Questionnaire 
(for instance being unable to stand up from a straight chair) already led to a higher risk 
of cardiovascular disease.
Because several studies have shown that obesity is causal in both disability and oA 
we stress the need for the prevention of overweight in vulnerable periods in life, for 
example during menopause and young adulthood.78 This suggestion for the prevention 
of overweight is not derived directly from our findings, but it is clinically relevant, at 
least in western industrialized countries; due to rapid aging the prevalence of chronic 
conditions such as obesity will rise. In addition, campaigning for healthy eating, 
weight control and exercise in younger populations is likely to be more cost-effective 
than the treatment of the pain and disability that result from overweight later in life.79 
Although aggressive marketing strategies by food companies and a long lag period 
between weight gain and clinical oA or disability complicate successful intervention, 
there are strong indications from observational studies that avoiding weight gain re-
duces the odds of developing oA.79-81 Also obese patients with knee oA could benefit on 
a functional and structural level taking into account the following ‘lifestyle-rules’82-84:
 1. Lose weight when overweight or obese.
 2. Be as physically active as possible.
 3. Replace sedentary time with light activity.
Generally, the self-awareness of health and identification of risk factors needs more 
attention, which should also result in a better prevention of cardiovascular events.85
oA is a disease with a high rate of comorbidities (68-85%).86,87 hypertension, diabetes 
type II, dyslipidemia, and obesity are most often mentioned as comorbid disorders in 
prevalence studies.88,89 oA can thus also be seen as a multimorbid disorder. The concept 
of multimorbidity (i.e. coexistence of 2 or more chronic conditions) needs further con-
sideration. Disorders not seen as the primary condition are often undertreated90 and 
there are patterns of multimorbidity beyond chance.91 visual impairment in particular 
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deserves more attention. It often co-exists with oA16,73, leads to activity limitations and 
might reflect a burden of vascular disease that has accumulated over time. Also, obesity 
is underexposed, but plays a central role in many conditions.
In a few medical specialties, attempts at paradigm shifts are being made. Recently, the 
American college of cardiology strongly suggested to change current treatment strate-
gies in cardiac care by involving comorbidities such as chronic obstructive pulmonary 
disease.92 We support adding comorbidities to current treatment guidelines; especially 
chronic diseases that influence physical functioning deserve extra attention. Sooner or 
later, multimorbidity will lead to disability, poor quality of life and an elevated risk of 
dying.93 We found indications for this pathway in chapter 6. We therefore also advo-
cate a more generalistic view of health, transcending medical specialties. A first step 
could be to adjust current treatment guidelines for comorbid disorders. Altogether, the 
management of multiple diseases in particularly the elderly requires complex therapy 
and care, and remains an important challenge in health care. General practitioners 
might be the ones best equipped to provide this complex form of care, also because the 
majority of people is treated within primary care facilities.
Future research
Although epidemiological studies on atheromatous vascular disease and oA – by us and 
others – have contributed to our understanding of the aetiology of both atherosclerosis 
and oA, many aspects remain unclear. Several unanswered questions have already 
been mentioned throughout this chapter and are shortly repeated below.
A metabolic oA phenotype might exist that affects knee and especially hand joints 
among women. Inflammatory mediators secreted by adipose tissue could be the most 
important actors, explaining the co-occurrence of vascular disease and oA (multimor-
bidity). Therefore, oA as a multimorbid disorder on the whole might be a direction for 
future research. unselected general populations are a promising source of information 
to gain insight into patterns of multimorbidity. In addition, the complex relation be-
tween obesity, menopause and oA needs to be studied more extensively. The possible 
moderating effect of menopause on the association between obesity and oA could be 
investigated by a structural equation modeling approach taking latent variables into 
account. Finally, the role of popliteal atheromatous disease and surrounding adipose 
tissues in the development of knee oA needs further consideration, similar to the 
retinal vasculature as a reflection of oA activity.
I have stressed the importance of large population-based studies for studying in-
cidence and determinants of chronic disease in this thesis. however, to understand 
the underlying pathophysiology of atherosclerosis and oA, we have to combine the 
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knowledge derived from epidemiological studies with discoveries in the field of basic 
immunology and human genetics, i.e. interdisciplinary research. The implications of 
insights for clinical practice can be addressed in appropriate clinical trials.
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Summary
osteoarthritis (oA) is the most frequent joint disorder worldwide and causes a consider-
able burden of pain, disability, and ever increasing costs to society. oA is considered 
to be a multifactorial disease and its aetiology involves biomechanical, genetic, in-
flammatory and hormonal factors. Several studies have identified age, female sex and 
obesity as key risk factors for oA. The involvement of other potential risk factors such 
as diabetes, menopause, and cholesterol in the disease process suggests that oA could 
be part of the metabolic syndrome, a condition with as its main characteristic systemic 
inflammation caused by visceral adipose tissue. An important clinical manifestation of 
the metabolic syndrome is atherosclerosis. 
Atherosclerosis is the underlying cause of 50% of all deaths in western societies. It is a 
multifactorial progressive condition characterized by the accumulation of lipids and 
fibrous elements in the arterial walls. eventually, accumulation of risk factors (age, 
hypertension, diabetes mellitus, obesity) leads to an acute clinical event (such as a 
myocardial infarction or stroke) as a result of plaque rupture and thrombosis. 
Because several epidemiological studies indicated a relation between subclinical mea-
sures of atherosclerosis and oA, we examined oA as a risk factor for cardiovascular 
disease and focused on the chronic inflammatory process of atherosclerosis and its 
relation with osteoarthritis in a population-based setting. Previous studies hypoth-
esized that atherosclerosis and oA could either be concurrent diseases with a shared 
aetiology or that atherosclerosis could play an initiating role in oA; circulatory dis-
turbances in the synovial membrane and subchondral bone could contribute to the 
cartilage destruction and the pathophysiological process of osteoarthritis. This may 
occur through mechanical changes of the subchondral bone, or more directly through 
bone-derived cytokines causing degradation of the cartilage.                                      
The overall goal of this thesis was to investigate whether atherosclerosis and oA are 
concurrent conditions with shared pathophysiological mechanisms or rather that ath-
erosclerosis acts as a risk factor for oA. All studies were performed within the frame-
work of the large population-based Rotterdam Study, comprising a huge data set of an 
adult population with prospective data on a large number of objective measurements 
of atherosclerosis, confounding factors as well as on features of local and widespread 
oA over a ten-year period. Chapter 2, 3, and 4 report on atherosclerosis and oA as 
concurrent diseases and atherosclerosis as an initiator or progressor of oA. 
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In chapter 2, we examined whether vascular alterations (carotid intima media thick-
ness and carotid plaque) were associated with the presence and progression of oA of the 
knee, the hip, and the different hand joints among 2,372 men and 3,278 women in the 
first cohort of the Rotterdam Study. Independent associations between subclinical ath-
erosclerosis and prevalent oA of the knee and hand joints were found among women. 
The evidence was most solid for a relation with distal interphalangeal oA of the hands. 
The same cohort, only older was investigated in chapter 3. Additional markers of early 
and late atherosclerosis in relation to presence and progression of knee osteoarthritis 
were evaluated. Serum levels of biomarkers of early atherosclerosis (CD40L and vCAM-
1) were higher in women with knee oA than in those without. The same did not hold 
for men. These findings are in line with the hypothesis that atherosclerosis and oA 
are concurrent diseases with a shared aetiology, possibly systemic low-grade inflam-
mation, among women. however, in chapter 4, cross-sectional associations between 
subclinical atherosclerosis and oA could not be replicated among younger middle-aged 
women (third cohort of the Rotterdam Study) and early features of knee osteoarthritis 
detected with sensitive magnetic resonance imaging. In addition, we could not show 
an association between atherosclerosis and incidence or progression of oA (chapter 
2 and 3) and could thereby not confirm an initiating role for atherosclerosis in the 
development of oA.
Classical observational studies into the causal relation between a risk factor and a 
disease can result in contradictory findings due to confounding factors. For osteoar-
thritis this might be the case with type 2 diabetes. A solution is to conduct a Mendelian 
randomisation (MR) analysis, which uses genetic variation as a surrogate marker for 
the risk factor (Instrumental-variable-approach). We explored this method in chapter 
5 and found that persons with genetically defined elevated levels of fasting glucose 
and fasting insulin were not at higher risk of oA. however, the power of a MR analysis 
depends on the fraction of total variance explained, which was relatively low (0.9% and 
0.4%). Therefore, similar analyses should be done when further genetic associations 
with glycemic traits are discovered, and in a larger context.
The main objective of Chapter 6 was to examine whether physicians should consider 
oA patients at high risk of cardiovascular disease (CvD). Previous studies found an 
association between oA and risk of CvD and therefore suggested intensive treatment 
of cardiovascular risk factors in oA patients, similar to conditions such as rheumatoid 
arthritis or gout. Yet, prospective population-based data was lacking. Before implement-
ing oA as another red flag into CvD prevention guidelines, we considered it necessary 
to critically assess this claim in a robust population-based study. We demonstrated 
that oA is not an independent risk factor for the development of incident CvD in a 
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population-based setting. our recommendation is therefore not to include oA into CvD 
prevention guidelines.
Chapter 7 reflects on the main findings of this thesis. We could not show an asso-
ciation between atherosclerosis and the incidence or progression of oA and could 
thereby not confirm an initiating role for atherosclerosis in the development of oA. 
Furthermore, oA was not a risk factor for incident cardiovascular disease. on the other 
hand, atherosclerosis was associated with prevalent oA of the knee and hand joints 
among women. A metabolic oA phenotype might exist that affects knee and especially 
hand joints among women. Inflammatory mediators secreted by adipose tissue could 
be the most important actors, explaining the co-occurrence of vascular disease and oA 
(multimorbidity). Therefore, oA as a multimorbid disorder on the whole might be a 
direction for future research. 
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Artrose is wereldwijd de meest voorkomende gewrichtsaandoening en leidt tot pijn, 
fysieke beperkingen, en almaar stijgende kosten voor de samenleving. De ziekte wordt 
gezien als een multifactoriële aandoening en is het eindresultaat van biomechanische, 
genetische, inflammatoire en hormonale oorzaken. verschillende studies laten zien dat 
leeftijd, het vrouwelijke geslacht en obesitas belangrijke risicofactoren zijn voor het 
krijgen van artrose. De invloed van andere potentiële risicofactoren zoals diabetes, de 
menopauze, en cholesterol suggereert dat artrose deel uitmaakt van het zogenaamde 
metabool syndroom. een syndroom met als belangrijkste kenmerk systemische ontste-
king, mogelijk als gevolg van visceraal vetweefsel. een belangrijke klinische uiting van 
het metabool syndroom is atherosclerose.
Atherosclerose is de onderliggende oorzaak van 50% van alle sterfgevallen in westerse 
samenlevingen. het is een progressieve, multifactoriële aandoening die gekenmerkt 
wordt door de opbouw van lipiden en vezelachtige elementen in de arteriële wand 
(plaque-vorming). uiteindelijk leidt een combinatie en opeenstapeling van risicofacto-
ren (leeftijd, hypertensie, diabetes mellitus, obesitas) tot een plaque ruptuur en trom-
bosering of afsluiting van een arterie. Deze indrukwekkende consequentie van het 
atherosclerotisch proces worden in de klinische setting ook wel acuut cerebrovasculair 
accident (beroerte) of myocardiaal infarct (een hartaanval) genoemd. 
omdat een aantal epidemiologische studies een relatie lieten zien tussen subklinische 
maten van atherosclerose en artrose, hebben we onderzocht of artrose een onafhan-
kelijke risicofactor is voor hart- en vaatziekten. ook hebben we ons gericht op het 
chronische inflammatoire proces van atherosclerose en de relatie met artrose in een 
open-populatiestudie. eerdere studies postuleerden dat atherosclerose en artrose ofwel 
gelijktijdige ziekten met een gedeelde etiologie waren of dat atherosclerose een initi-
erende rol speelde bij artrose; doorbloedingsstoornissen in de synoviale membraan en 
het subchondrale bot zouden kunnen bijdragen aan destructie van kraakbeen en het 
pathofysiologische proces van artrose. Mechanische veranderingen van het subchon-
drale bot of van het bot afkomstige cytokinen zouden verantwoordelijk kunnen zijn 
voor deze afname van kraakbeen.                                  
het doel van dit proefschrift was om te onderzoeken of atherosclerose en artrose gelijk-
tijdig optredende ziektes zijn met overeenkomstige pathofysiologische mechanismen 
of dat atherosclerose juist een risicofactor is voor het ontwikkelen van artrose. Alle 
studies zijn uitgevoerd binnen het raamwerk van de eRGo-studie, een grote open-
populatie studie met een enorme hoeveelheid data van een volwassen populatie. We 
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beschikten daarmee over prospectieve data van zowel objectieve atherosclerose maten, 
verstorende factoren (confounders), als artrosekenmerken. Hoofdstuk 2, 3, en 4 gaan 
over atherosclerose en artrose als gelijktijdig voorkomende ziektes en atherosclerose 
als een initiator of progressor van artrose.
In hoofdstuk 2 onderzochten we bij 2372 mannen en 3278 vrouwen in het eerste cohort 
van de eRGo-studie of vaatveranderingen (intima-media-dikte en plaque vorming in de 
arteria carotis) geassocieerd waren met de aanwezigheid en progressie van artrose van 
de knie, heup, en handgewrichten. Bij alleen de vrouwen werden onafhankelijke as-
sociaties tussen de bovengenoemde atherosclerose-maten en prevalente artrose van de 
knie en handgewrichten gevonden. het bewijs was het meest  robuust voor een relatie 
met distale interphalangeale artrose van de handen. hetzelfde cohort, alleen ouder, 
werd onderzocht in hoofdstuk 3. Additionele markers van vroege en late atheroscle-
rose werden onderzocht in relatie met de aanwezigheid en progressie van knie-artrose. 
Biomarkers van vroege atherosclerose (CD40L en vCAM-1) waren meer aanwezig in het 
plasma van vrouwen met knie-artrose vergeleken met het plasma van vrouwen zonder 
knie-artrose. Bij mannen werd dit verschil niet teruggevonden. Deze bevindingen 
komen overeen met de hypothese dat atherosclerose en artrose bij vrouwen gelijktij-
dig optredende aandoeningen zijn met een gedeeld pathofysiologisch mechanisme, 
mogelijk systemische laaggradige inflammatie. echter, in hoofdstuk 4 konden de 
cross-sectionele associaties tussen subklinische atherosclerose en artrose niet worden 
gerepliceerd in een cohort met jongere vrouwen. Bij deze jongere vrouwen (derde 
cohort van de eRGo-studie) beschikten we over de magnetische resonantie techniek 
die kenmerken van knie artrose in een vroeg stadium kunnen afbeelden. Daarnaast 
vonden we geen associatie tussen atherosclerose en de ontwikkeling (incidentie en 
progressie) van artrose (hoofdstuk 2 en hoofdstuk 3) en konden we een initiërende rol 
voor atherosclerose bij de ontwikkeling van artrose daarom niet bevestigen.
Klassieke observationele studies naar de causale relatie tussen een risicofactor en een 
ziekte kunnen resulteren in tegenstrijdige bevindingen door verstorende factoren 
(confounding). Dit lijkt ook het geval bij diabetes mellitus type II als risicofactor voor 
artrose. een mogelijke oplossing is een analyse op basis van Mendeliaanse randomisatie, 
waarin genetische variatie als surrogaat-marker voor een risicofactor voor een ziekte 
wordt gebruikt (Instrumentele-variabele-analyse). We onderzochten deze methode in 
Hoofdstuk 5 en vonden dat personen met genetisch verhoogde nuchtere glucose en 
insulinewaarden geen hoger risico op artrose hadden. echter, de verklaarde variantie 
van de nuchtere glucose en insulinewaarden was laag en vergelijkbare analyses in een 
grotere context moeten worden uitgevoerd om uitspraken te doen over diabetes mel-
litus type II als risicofactor voor artrose.
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In hoofdstuk 6 onderzochten we artrose als rode vlag voor hart-en vaatziekten (hvZ). 
voorgaande studies vonden namelijk een relatie tussen artrose en een verhoogd 
risico op hvZ en adviseerden een meer intensieve behandeling van cardiovasculaire 
risicofactoren bij artrose patiënten. helaas ontbrak het aan prospectieve data uit grote 
open-populaties bij deze studies. We vonden het daarom nodig om deze aanbeveling 
kritisch te onderzoeken in een robuuste open-populatie studie, vóór implementatie 
van artrose als additionele onafhankelijke risicofactor in de klinische praktijk. We 
lieten zien dat artrose geen rode vlag is voor de ontwikkeling van incidente hvZ. onze 
aanbeveling is daarom om artrose niet toe te voegen aan richtlijnen voor preventie van 
hart-en vaatziekten.
Hoofdstuk 7 reflecteert op de belangrijkste bevindingen in dit proefschrift. We vonden 
geen relatie tussen atherosclerose en incidentie of progressie van artrose en konden 
daarom niet bevestigen dat atherosclerose een initiërende rol heeft in de ontwikkeling 
van artrose. Daarnaast was artrose geen risicofactor voor hart-en vaatziekten. echter, 
subklinische atherosclerose was wel geassocieerd met de aanwezigheid van knie- en 
handartrose bij vrouwen. er zou een metabool artrose fenotype kunnen bestaan dat 
de knie- en vooral de handgewrichten aantast bij vrouwen. Door het vetweefsel uit-
gescheiden cytokines kunnen tot een chronische ontstekingsreactie leiden en zouden 
een verklaring kunnen zijn voor het gelijktijdig voorkomen van atherosclerose en 
artrose (multimorbiditeit). Toekomstig onderzoek zal dit moeten uitwijzen. 
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De afronding van dit proefschrift was nooit gelukt zonder de hulp, kritiek, humor 
en mental support van velen. Bedankt daarvoor. onderstaande personen wil ik in het 
bijzonder noemen.
Allereerst mijn beide promotoren, prof.dr. Sita Bierma-Zeinstra en prof.dr. oscar 
Franco. Beste Sita, je bent niet voor niets promotor-of-the-year 2013 geworden. voordat 
ik aan dit project begon hoorde ik van verschillende mensen dat ik geen betere bege-
leiding kon wensen; daar hadden ze gelijk in. Bedankt voor de vele goede gesprekken 
en je kritische, maar constructieve commentaar. Dat je ook nog op de hoogte bent van 
goede Scandinavische muziek maakt de kous af. 
estimado oscar:  muchas gracias por tus consejos y por tu tiempo, ya que pude contar 
contigo en todo momento. Muchas veces pocas palabras fueron suficientes para enten-
dernos. esperaré todavía con mucho agrado que vengas un día a jugar fútbol (7t7) con 
nuestro ‘equipo Bastardo’.  Deseo que te quedes mucho tiempo en “la Torre” del Centro 
Médico erasmus.
Beste prof.dr. Albert hofman, bedankt voor je bijdrage aan de eRGo-studie en de kans 
die je aan geneeskunde studenten hebt gegeven om tijdens hun studie de research mas-
ter Clinical epidemiology te volgen. Dit heeft naast een groot aantal mooie onderzoeken 
in uiteenlopende medische disciplines ook zeer waardevolle vriendschappen opgeleverd. 
Beste prof.dr. Patrick Bindels, de north American Primary Care Research Group 
(nAPCRG) bijeenkomsten waren zeer inspirerend, huisartsgeneeskundig relevant, en 
ook gezellig. Met name die in muziekstad new orleans kan ik me goed herinneren; ik 
vraag me nog steeds af wat er was gebeurd als je wel de saxofoon had opgepakt tijdens 
één van de jamsessies. Super dat wij als AIoThos naar deze bijeenkomsten konden 
gaan, hopelijk is het de start van een lange traditie.
Beste prof.dr. Jacqueline Witteman, bedankt voor je eerlijkheid en buitengewone 
intelligentie. 
Beste Joyce, jouw scherpe vragen over gekozen methodologie, ongezouten kritiek op 
geschreven stukken en enorme kennis van de genetica hebben me geholpen om af en 
toe boven mezelf uit te stijgen.
Alle medewerkers binnen het eRGo-centrum en eRGo-deelnemers; jullie zijn al volop 
acknowledged in de gepubliceerde artikelen, nu nogmaals: het onderzoekscentrum in 
ommoord is een interessante en bijzondere plek, jullie collegiale ondersteuning, bv bij 
het opstarten en instellen van het oeroude (>20 jaar!) maar robuuste MS DoS-systeem, 
heeft heel wat stress voorkomen. Wie weet kom ik er ooit nog een keer als huisarts terug. 
Collega’s van de (cardiovasculaire) epidemiologie; ik sluit me volledig aan bij het 
commentaar van meerdere reviewers, namelijk dat jullie een excellente groep zijn: 
wat een kwaliteit! Maarten, met jou heb ik het stuk geschreven waar ik het meest trots 
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op ben, bedankt voor het meedenken en je uitzonderlijke methodologische kennis. Ik 
hoop voor je dat Feyenoord nog een keer kampioen wordt. Maryam, ik herinner me 
naast de methodologische discussies en dilemmas ook de waardevolle gesprekken over 
onderwijs en opvoeding. Succes in je ongetwijfeld succesvolle verdere wetenschappe-
lijke loopbaan. Paul, je hebt me bij de laatste loodjes enorm geholpen, het waren fijne 
gesprekken, heb veel van je geleerd op genetisch gebied. Abbas, Symen, Frank, Arfan, 
Renée, Klodian en Sanaz, jullie ook bedankt. 
Graag wil ik ook de aangename sfeer op de afdeling huisartsgeneeskunde noemen. 
Meer specifiek de huisartsopleiders bedanken voor hun voorbeeldfunctie, de “front-
line officers” voor de relativering en humor, en de onderzoekers voor hun collegialiteit, 
vriendschap en solidariteit. Speciale dank voor Jos en Dieuwke, 2 super-post-docs, die 
me vooral bij de start van het onderzoek enorm hebben geholpen. erwin, zonder jouw 
hulp zou de afronding van dit boekje een stuk langer hebben geduurd, onze gesprek-
ken gaven me weer een duwtje in de goede richting. 
Beste Jan hendrik en egil, onze tijd samen in ruraal Bangladesh is belangrijk geweest 
voor me. Ik heb er veel geleerd over epidemiologisch onderzoek, armoede, en infectie-
ziektes. Jullie begeleiding daarin was nodig en waardeer ik zeer. er is een vlammetje 
aangegaan dat niet zal doven. 
Lynn en Joost, bedankt voor de hulp bij de wording van dit proefschrift. naast dat 
jullie erg goed zijn in wat jullie doen, zijn jullie erg fijne vrienden.
Dan de paranimfen, Christiaan en Daniël. Al heel lang zijn jullie bij vrijwel alle mooie 
en minder mooie momenten in mijn leven betrokken. Personen met wie je lichte en 
zware periodes doormaakt zijn er om te koesteren. Ik kan me geen betere bodyguards 
voorstellen nu. Laten we er iets moois van maken. vincent, jammer dat je er niet bij 
kunt zijn, maar jij mag hier natuurlijk niet ontbreken. hopelijk tot snel in Boston, 
Breda, of Rotterdam met jullie nieuwe aanwinst.
Lily en herman, bedankt voor de interesse en de hulp bij het reilen en zeilen in en 
rondom ons huis. ook jullie waren en zijn altijd laagdrempelig bereikbaar. 
Marlies, Adrie, Rosanne, en Dave, ik heb geluk met jullie als familie. Dat ik vrij stevig 
op deze aardkloot sta is voor een groot deel op jullie conto te schrijven. Zoals opa 
Mariman altijd zei: “Ge wit ervan.” 
Lieve Line en Jade, jullie zijn de leukste onderzoekers die ik ken. ook de grappigste, 
mooiste en liefste trouwens. Papa houdt heel veel van jullie.
Lieve Jona, dit laatste en belangrijkste stukje heb ik 8 keer herschreven en blijft het 
moeilijkste van het hele proefschrift. Bedankt voor je wijsheid, kracht en hulp bij de 
noodzakelijke frameshifts in deze turbulente periode. Je bedanken is niet genoeg. We 
hebben 2 prachtige dochters en ik zie ernaar uit samen nog veel van deze wereld te gaan 
zien. Speciaal voor jou zoals beloofd: “Filosofie is de koningin der wetenschappen.”
Beseffende dat ik ongetwijfeld nog veel mensen vergeten ben, wil ik het hierbij laten.
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Theun Antonius hoeven is op 7 juli 1983 geboren te Breda. Daar combineerde hij het 
Stedelijk Gymnasium met een opleiding tot professioneel voetballer (n.A.C.). na het 
vWo diploma woonde hij een jaar in Barcelona om Spaans te leren en te voetballen. 
In 2001 begon hij aan de studie Geneeskunde in Rotterdam, waar hij als lid van SToLA 
(Stages in ontwikkelingslanden) de Tropencursus organiseerde. In het tweede studie-
jaar werd hij uitgenodigd om de Master of Science in Clinical epidemiology te volgen 
bij het netherlands Institute of health Sciences. hierdoor kreeg hij de mogelijkheid om 
verschillende methodologische cursussen te volgen aan internationaal gerenommeerde 
opleidingsinstituten (o.a. harvard university (vS), Cambridge university (uK) en eras-
mus university (nL)). Lepra onderzoek in Bangladesh resulteerde in een internationale 
publicatie waarmee deze Master of Science werd afgerond. In 2008 behaalde hij ook 
zijn artsenbul en na een korte periode werkzaam te zijn geweest in de psychogeriatrie 
(Stadzicht Rotterdam) begon hij in 2009 aan de huisartsopleiding. Als AIoTho (Arts-
in-opleiding-tot-huisarts-en-onderzoeker) is hij sinds 2010 onderdeel van de afdeling 
huisartsgeneeskunde in het erasmus Medisch Centrum. Momenteel is hij bezig met het 
laatste jaar van de huisartsopleiding bij praktijk havenbogen te Schiedam.
Theun woont met zijn vrouw Jona, en dochters Line en Jade op Katendrecht, in Rot-
terdam.
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Vascular pathology and osteoarthritis are highly prevalent disorders that often co-occur and 
they have a large impact on quality of life. Focus in this thesis is on atherosclerosis (chronic 
inflammatory condition of the arterial wall) and its relation with osteoarthritis, a widespread 
joint disease (i.e. joint failure). Does atherosclerosis preceed osteoarthritis, or are they 
concurrent diseases with shared aetiological features, for instance systemic inflammatory 
effects of adipose tissue?
This thesis aims to answer these and other questions surrounding osteoarthritis and vascular 
disease. All studies derived from the Rotterdam Elderly Study, a prospective population-based 
cohort study in the Ommoord district in the city of Rotterdam, the Netherlands. 
The author was born on july 7th 1983 in Breda, the Netherlands. At the Erasmus medical center 
in Rotterdam, he was trained as a medical doctor and obtained a Master of Science degree in 
Clinical Epidemiology (Leprosy research). He started with the PhD project the role of vascular 
pathology in the development and progression of osteoarthritis in 2011 and is currently in his 
final year of a general practitioner traineeship.
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